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ABSTRACT
The global market for the medical diagnostic industry is worth 25 billion dollars in the
United States and is expected to grow exponentially each year. Presently available
methods for biodetection, such as immunoassays, chemiluminescence and fluorescent
based assays are expensive, time consuming and require skilled labor with high-end
instruments. Therefore, development of novel, passive colorimetric sensors and
diagnostic technologies for detection and surveillance is of utmost importance especially
in resource constrained communities.
The present work focusses on developing novel and advanced in vitro
biodiagnostic tools based on aptamer integrated biosensors for an early detection of
specific viral proteins or small biomolecules used as potential markers for deadly
diseases. Aptamers are short single stranded deoxyribonucleic acid (DNA) which are
designed to bind to a specific target biomolecule. These are readily synthesized in
laboratory and offers several advantages over antibodies/enzymes such as stable in
harsh environment, easily functionalized for immobilization, reproducibility etc. These
undergo conformational changes upon target binding and produces physical or chemical
changes in the system which are measured as colorimetric or electrochemical signals.
Here, we have explored the aptamer-analyte interaction on different platforms such as
microfluidic channel, paper based substrate as well as organic electrochemical transistor
to develop multiple compact, robust and self-contained diagnostic tools. These testing
tools exhibit high sensitivity (detection limit in picomolar) and selectivity against the target
molecule, require no sophisticated instruments or skilled labor to implement and execute,
leading a way to cheaper and more consumer driver health care. These innovative
iii

platforms provide flexibility to incorporate additional or alternative targets by simply
designing aptamers to bind to the specific biomolecule.

Keywords: Aptamers, point-of-care diagnostics, Organic electrochemical transistor,
microfluidics, epinephrine, Zika, Chikungunya, Gold nanoparticles, PDMS.
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CHAPTER 1: INTRODUCTION
1.1

Introduction to Biosensors

In the recent decade, the development of Point of care (POC) diagnostics has garnered
tremendous amount of attention due to its applications in the early diagnosis of diseases
which can be extremely helpful in the health care industry. The factors such as lack of
trained personnel, well-equipped centers and cost of biosensors are the some of the
obstacles which limit the use of diagnostic tools in the third world countries. WHO has
defined an idealistic biosensor to an ASSURED device which stands for Affordable,
Sensitive, Specific, User-friendly, Rapid and Robust, Equipment-free and Deliverable [13].
In vitro point of care testing refers to the examination of reagents such as bodily
fluids, tissues, cells etc using a combination of techniques, reagents or instruments with
the goal of detecting an analyte in a controlled environment outside living organism
(Figure 1). These devices offer the opportunity to perform the assay at the patient’s site
and obtain results rapidly and accurately with a limited infrastructure. The rapid testing
results in better patient management, reduces multiple visits, enable timely treatment and
more importantly, contain infectious disease. It has been reported that the successful
implementation of a 90% sensitive malaria POC testing device has the ability to prevent
unnecessary treatment worth of 450 million and save over 2.2 million lives. Testing
techniques with higher sensitivity but with minimal laboratory requirements will prevent
only 400 million unnecessary treatments. The potential of POCs to provide clinically
1

relevant information without the need for a laboratory setting or trained personal has
fueled the demand to generate new tools to diagnose broad spectrum of biomolecules.
8/22/2018
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From the research point of view, more than 73000 search items are displayed, when the
keywords “point of care” are searched in PubMed [4].

Figure 1: Multiplexed Point of Care Testing [5]
The demand for POC diagnostics has skyrocketed in recent years. The global in
vitro diagnostic market share has been estimated to exceed USD 70 billion by 2022
https://ars.els-cdn.com/content/image/1-s2.0-S0167779917300628-gr1_lrg.jpg
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according to Market search engine [6]. The major challenge is to bring the techniques to
patient’s site without compromising the sensitivity or accuracy of the approach. Figure 1
shows a schematic of a general multiplex POC testing where the blood is taken from an
individual, run and analyzed on a platform and the output signal is displayed on a smart
phone device. The platforms range from microfluidic channel, paper based sensors, use
of nanosized beads and plate based assays. The current available biosensors are
2

categorized on the basis of processes that translates the binding event into an output
readable signal. The next section explains different types of biosensor based on the
output signal that are available today.

1.2

Types of sensors

1.2.1 Colorimetric sensor
Metal nanoparticles exhibit unique size and shape dependent optical properties [7-12]. A
strong absorption band is observed in the UV-Visible spectra of the gold and silver
metallic nanoparticles when light is incident on them. This band is due to the interaction
of light with metal nanoparticles which results in collective oscillation of the electrons in
the conduction band and gives rise to strong surface plasmon resonance (SPR) signal
[13-15]. The SPR signal is highly dependent on the surface morphology of the material,
therefore any change in size, shape or the dielectric properties of the surrounding medium
will cause a shift in the electron density. This results in a change in the oscillation
frequency, generating different absorption and scattering spectrum. Typically for gold
nanoparticles smaller than 20 nm, the SPR band is seen at 520 nm which is in the range
of visible range as shown in Figure 2. Therefore, any shift in the absorption plasmon band
due to change in the morphology is visible through naked eyes without any external
excitation or emission source.[16] Figure 2B represents different colors of gold
nanoparticles which can be synthesized by varying the size. The UV-Visible spectra
shows the red shift with increasing size of gold nanoparticles. It can be seen that varying
the size of AuNPs from 10-100 nm causes red shift in the absorption spectrum from 520
to 580 nm (Figure 2A). These unique size-dependent optical properties of AuNPs along
3

with high extinction coefficient and high surface-to-volume has made them ideal
candidate in sensing applications.
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Figure 2: (A) Normalized absorbance of Gold nanoaprticles (AuNPs) with different sizes.
(B) Red-shift in the SPR peak with increasing diameter of AuNPs. Inset shows different
colored AuNPs with different sizes [16]

Target induced specific aggregation of the AuNPs has gained much attention in
recent decades in the detection and imaging world of biological targets. The surface of
the AuNPs can be easily functionalized with an acceptor molecule which shows high
affinity towards a specific target. For example, AuNPs functionalized with biotin shows
high affinity towards streptavidin. Exposure of these functionalized AuNPs to streptavidin
will induce agglomeration in the solution changing the color of the solution from red to
blue. This color change is due to the shifting of maximum SPR peak to longer wavelengths
(red shift). Antibodies and DNA strands have been widely used as biorecognition
elements to detect the presence of small molecules, proteins or other nucleic acid. The
role of these elements is two fold- first is to specifically bind to the molecule and second
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is to provide stability to the AuNPs and protect them against salt aggregation. The
detection of DNA strand is done by functionalizing the surface with a single stranded (ss)
DNA. In the presence of the complimentary strand, the ssDNA strand is released leaving
the AuNPs surface exposed eventually leading to aggregation [17]. The similar approach
has been used for the detection of dopamine, thrombin and cocaine [18, 19] in which the
surface of AuNPs is functionalized with DNA designed for the specific target molecule.

7/22/2018
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Figure 3: Schematic showing mechanism behind colorimetric detection of metal ions
https://ars.els-cdn.com/content/image/1-s2.0-S0925400516309339-gr2_lrg.jpg
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using AuNPs. (A) The presence of metal ions causes AuNPs to aggregate and change
the color from red to blue. (B) Presence of metal ions causes disassembly of AuNPs
changing color from blue to red. [20]
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The schematic of the working of a basic AuNPs based colorimetric sensor has
been shown in Figure 3 [20]. The presence of analyte can lead to (a) aggregation of
AuNPs or (b) disassembly of aggregated AuNPs. The aggregation of AuNPs is followed
by broadening of the SPR band and change in visual color from red to blue due to the
size dependent optical property. However, the disassembly causes a change from blue
to red and blue shift in the SPR absorption band.

1.2.2

Enzyme-linked immunosorbent Assay

The basic principle of ELISA was pioneered in 1971 by two Swiss scientists: Engvall and
Perlmann [21-23]. They modified Radioimmunoassay (RIA) method by replacing
radioactive iodine with enzymes. Because of the hazardous effect of using radioactive
iodine, RIA assays were modified, thus creating modern day ELISA technique. The initial
research work were focused on determining the level of IgG in rabit serum and quantifying
human chorionic gonadotropin in urine using horseradish enzyme [21, 23]. After the
invention of ELISA, a lot of work was done in the field of diagnostic microbiology,
parasitology and to detect viral proteins such as influenza, parainfluenza, mumps etc in
the year 1973-1981 [24-29].
The working of ELISA is based on interaction of antigen to its specific antibody,
which makes it possible for the detection of very small amount of antigen such as proteins,
peptides

or

antibodies

in

a

fluid

sample.

ELISA

utilizes

enzyme

labelled

antigens/antibodies to achieve an amplified output signal in the presence of very small of
antigen. The common enzymes used are glucose oxidase, alkaline phosphatase,
horseradish peroxide etc which yields a change in color or a fluorescence signal in the
6

presence of the molecule of interest. Quantitative analysis is done by measuring the
intensity of fluorescent signal or color change which is further analyzed by a reader.
Various modifications in the process of ELISA has been done in the recent decade as
shown in Figure 4. These are as follows:
(a)

Direct ELISA- The direct type of ELISA involves the immobilization of antibody/antigen

on the surface of the plate. The enzyme tagged antibody/antigen is introduced and incubated for
a particular amount of time, after which the plate is washed off to remove unbound material from
the wells. An appropriate substrate is added to the well which produces an output signal through
development of color.
(b)

Indirect ELISA- The process includes the involvement of an enzyme tagged secondary

antibody which attaches to the primary antibody-antigen complex and helps in the development
and quantification of a signal. This type of method was first developed by Lindström and Wager
in 1971 to measure porcine IgG antibody [30].
(c)

Sandwich assay- The sandwich assay includes capturing an antigen between two

different types of antibodies- capture and detection antibody. The capture antibody is immobilized
on the surface of plate which attaches to the antigen and then detection antibody tagged with an
enzyme is added which gives the output signal in the presence of a substrate. The signal is directly
proportional to the concentration of the antigen [31].
(d)

Competitive assay- The surface of the wells is immobilized with antibodies specific to the

antigen. The sample containing antigen is added in the wells along with another tagged antibody.
The immobilized antibody competes with the tagged antibody to bind to the antigen present in the
well. The excess antibody is washed off and substrate is added to produce the signal. The signal
is inversely proportional to the concentration of the antigen in the serum [22].
(e)

Nanoparticle based immunoassay- Recently, nanoparticles have been utilized to

develop novel immunoassays due to their unique physical, chemical and biological properties.
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These materials have been adapted to improve the degree of sensitivity of a biosensor due to
their potential for operating without enzymes or replacing enzymes overall [32]. The surface of
the nanoparticles can be easily modified with target binding molecules and due to their existence
in different colours, the need of substrate is entirely unnecessary. The application of nanoparticles
in the detection of heavy metal ions, proteins, peptides, DNA and even cells have shown great
potential attributing to their enhanced stability and cost effectiveness of the developed sensors.

Figure 4: Different types of ELISA techniques [22].

1.2.3 Organic Electrochemical transistors

https://ars.els-cdn.com/content/image/1-s2.0-S019697811500131X-gr1_lrg.jpg

The field of organic transistors provide an attractive means for the detection and
quantification of biomolecules for the applications in medical and health care industry [3336]. The miniaturization, easy electrical read out signals, signal amplification as well as
robustness are the key advantages of these devices which have given them an edge over
8
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other approaches. A wide range of sensors such as pressure, humidity, pH, mechanical
deformation and ion concentrations etc have been successfully developed using the
organic transistors[37-39].

Figure 5: A flowchart showing different components of a biosensor [34].
All these sensors have different functions; however, the basic schematic comprises of the
following entities (Figure 5):
(a) Bioreceptors (enzyme, antibodies, aptamers etc) which is specifically designed to bind the
analyte molecule.
(b) Electrical interface- where the specific biological event such as binding, redox reaction etc
takes place.
(c) Signal amplifier- The transduction and amplification of the biological event into an output
electrical signal.
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(d) Signal processor- The computer software which converts the change in electrical signal in
some form of physical parameter which is read though display.
(e) Display-an interface between the computer and the human operator which displays the
detection and quantification parameters in readable form.

Different operating modes of a transistor include amperometric (change in current),
conductimetric (change in conductivity of the medium) and potentiometric (change in
potential) sensors [37, 40-42]. The major class of electrochemical detection techniques
utilizes field-effect transistor in which the change in current is measured due to the change
in potential at the gate electrode. Within the family of FETs, an organic electrochemical
transistor (OECT) consists of two electrodes- source and drain connected by an active
layer of semiconductive material and a third electrode called gate which controls the
conductivity of the channel. A typical OECT based biosensor involves the modification of
metal gate electrode with a biologically active component (bioreceptors such as enzyme,
antibodies, aptamers etc) which transduces an electrochemical signal in the presence of
specific analyte [43]. The working of the device depends on the doping/de-doping of the
semiconducting layer bridging the channel. The transistor is a combination of sensor as
well as amplifier where a small change in the potential causes significant change in the
current. This occurs in low operating voltages which is suitable for biological and chemical
sensing in aqueous environment [44].
Researchers have been emphasizing on the use of nanotechnology to shrink the
dimensions of the device which will ensure high signal to noise ratio, small sample usage
and ultimately a more compact device. Research has also been focused on the advent of
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new bioreceptors molecules which offers high specificity and affinity towards the molecule
of interest. Most of the electrochemical sensors depend on the use of some electroactive
label molecule (Fluorescent, chemiluminescent or radioactive labels) which facilitates the
transfer of electron in the presence of analyte resulting in a change in the potential. The
major drawback of using labels is to immobilize the label molecule over the analyte and
the limited stability of the label in harsh environmental conditions. Therefore, lot of
research has been done towards exploring label free biosensors to develop more reliable
biosensors for practical applications [45-47]. An ideal biosensor is stable at a wide range
of temperature, pH and humidity and does not show variations between different assays.
It is cheap, portable, compact, user-friendly and provides real-time analysis in a timely
fashion.

1.3

Introduction to Aptamer

The word aptamer is taken from Latin word ‘aptus’ which means to fit [48, 49]. Therefore,
the word aptamer denotes a kind of polymer which fits to its target. Aptamers are short
synthetic strands of oligonucleotides either, DNA or RNA which specifically binds to a
target molecule. These are designed and selected through Systematic Evolution of
Ligands by Exponential Enrichment (SELEX) procedure. First a combinatorial library of
random oligonucleotide sequences is formed. A target molecule is incubated with the
random sequences in an appropriate buffer and at particular temperature and pH. Then,
the free nucleotides are washed away and bound nucleotides are eluted. This process
consists of repetitive steps alternating between selection and amplification by using PCR
11

(polymerase chain reaction). The strands showing highest affinity towards the target
molecule with Kd value in the nanomolar to picomolar range are extracted. It can be noted
that the process of SELEX does not necessarily favor the production of aptamer for a
single epitope on the given target. Till now, a wide range of aptamers has been designed
for targets such as nucleic acid [50], proteins [51, 52] small organic molecule [53], metal
ions [54], viruses [55], bacteria [56] and antibiotics. Aptamer can bind to the target
molecule by a lock and key mechanism through conformational change (Figure 6) and
other forces such as van der Waals interactions, hydrogen bonding and electrostatic
interactions also play a major role [49].

Figure 6: Schematic diagram showing the conformational change in the presence of a
target molecule [57]

1.3.1 Aptamer vs Antibodies
When compared with antibodies, aptamer provide numerous advantages. Some of them
are as follows:
A. Synthesis- Antibody are extracted by an in vivo process using animal’s immune
12

response against a particular target whereas aptamers are chemically synthesized by
SELEX process.
B. Reproducibility- Chemical synthesis of aptamers reduces batch-to-batch variation in
aptamer and also reduces cost of production. These can be synthesized with high
degree of purity, extreme accuracy and reproducibility.
C. Ease of functionalization- Aptamers ends can be functionalized easily with labels or
other molecules for easier immobilization or target purification.
D. Stability- Antibodies are very sensitive to the variation in temperature or pH and can
easily undergo denaturation. On the other hand, the aptamers are stable at high
temperatures and can be renatured within few minutes to maintain the structure.
E. Aptamers have been a good alternative to antibodies. However, a major drawback of
using aptamer is degradation by nucleases. Therefore, the entire experiment has to
be done in a DNAase - RNAase free environment.
1.4

Scope of the thesis

The scope of the present thesis is to develop novel diagnostic tools for application in the
point of care testing devices. The present thesis is organized in the following chapters.
Chapter 2 demonstrates the development of a colorimetric sensor based on the
aggregation of gold nanoparticles in the presence of specific analyte molecule. A detailed
study to investigate the role of physical morphology of AuNPs, aptamer concentration as
well as the effect of salt has been performed to better understand and control the
sensitivity of the approach.
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Our goal in chapter 3 is to detect epinephrine in picomolar range using an
electrochemical platform. The novelty in this work is the use of aptamer modified gate
electrode which regulates the output current in the presence of epinephrine. The device
exhibited high sensitivity (90 pM detection range) and specificity for epinephrine (no
response towards common interfering agents) due to the use of aptamers.
In Chapter 4, an attempt has been made to develop a multiplex analyte detection
system using a PDMS based microfluidic channel which gives an easy colorimetric
readout signal. Zika and Chikungunya envelope proteins has been detected at picomolar
range with naked eye detection using aptamer functionalized micro-pillars. The use of
microfluidic channel offered advantages such as smaller sample volumes, lower cost,
easy disposal as well as high throughput. Finally, chapter 5 discusses the conclusions
and future work for the advancement of the thesis.
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CHAPTER 2: COLORIMETRIC DETECTION OF EPINEPHRINE USING
AN OPTIMIZED PAPER-BASED APTASENSOR
The work presented in this chapter has been published in

RSC Advances, 2017, 7, 49133-49143; DOI:10.1039/C7RA10272K
Reproduced by permission of The Royal Society of Chemistry.

2.1

Introduction

The global market for medical diagnostic industry is worth 25 billion dollars in the United
States and will continue to grow each year [58]. Presently, available methods for
biodetection, such as immunoassays, [59, 60] chemiluminescence [61-63] and
fluorescent based assays, [64, 65] are expensive, time consuming and require skilled
labor with high-end instruments. Therefore, development of novel, passive colorimetric
sensor and diagnostic technologies for detection and surveillance has garnered utmost
importance. Paper-based sensors employing gold nanoparticles (AuNPs) as colorimetric
probes have gained attention due to their simplicity, robustness and scalability [66-68].
These sensors are easy to fabricate and are capable of handling very small volumes of
liquid (microliter) which greatly reduces reagent and sample consumption.
Gold nanoparticles (AuNPs) exhibit unique optical properties due to their bright red
color in solution which is highly dependent on the interparticle distance.[7, 69] Despite
being the noble metal in the bulk state, AuNPs act as catalysts in nanoscale and therefore
show promising applications in electronics, [70] photonics, [71] chemical sensing and
imaging [72-74]. The optical properties of AuNPs can be tuned throughout visible to near
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infra-red spectra by varying AuNPs size, shape, local environment and aggregation state
[14, 75-79]. When AuNPs of ~10-20 nm size are uniformly dispersed in solution, they
exhibit a strong plasmon peak at ~520 nm due to the collective oscillations of the free
electrons in the conduction band. Any change in physical parameters will cause a shift in
the electron density, resulting in changes in oscillation frequency, absorption and
scattering spectra and hence, the visible color of the AuNPs solution from red to blue.
This approach can be used to design simple biosensing devices to detect various kinds
of molecules.
Aptamer-functionalized gold nanoparticles (AuNPs-apt) have also attracted
attention for use in detecting small proteins, [58, 80-83] oligonucleotides [19, 75, 84, 85]
and metal ions [86-88] due to their low cost, simplicity and practicality [89-92]. Aptamers
are short, synthetic oligonucleotide strands of either DNA or RNA which are synthesized
by a procedure called Systematic Evolution of Ligands by Exponential Enrichment
(SELEX) and can be functionalized onto the surface of a nanoparticle [53], [93]. These
sensory molecules bind to target molecule by a lock and key mechanism driven by a
conformational change as well as van der Waals forces, hydrogen bonding and
electrostatic interactions [49]. This binding cause energy/charge transfer between the
AuNPs-apt and the target, leading to aggregation in the solution. The target-mediated
aggregation of AuNPs-apt results in the color change of the colloidal gold solution from
red to blue [94, 95]. This attribute of AuNPs of transferring any biorecognition event into
a color change has motivated scientists to use AuNPs as a biosensing tool for the
detection of numerous biomolecules including oligonucleotides, small proteins,
biomarkers and pathogens.
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The

catecholamine

epinephrine

(methylamino)ethyl]benzene-1,2-diol) is

(4-[(1R)-1-hydroxy-2-

a neurotransmitter and neuroendocrine

hormone which acts upon α-adrenergic and β-adrenergic receptors in several organs,
giving it a vast array of physiological functions [96]. Clinical uses include the treatment of
anaphylactic shock, cardiac attack and asthma attacks [96]. Abnormalities in epinephrine
levels may result in myocardial infarction, arrhythmias, pulmonary edema, blood pressure
increase and Takotsubo cardiomyopathy [97-99]. The level of epinephrine present in the
plasma is approximately 13.6 x 10-11 M [100]. Detection has previously been performed
by

electrochemical

methods,

[101-103]

liquid

chromatography,

[104,

105]

spectrophotometry, [106] electrophoresis, [107] flow injection analysis [108, 109] and
fluorometry [48, 110]. The estimated detection limit for epinephrine obtained from all these
experiments was found in the range of nanomolar to micromolar (10-8 to 10-9 M) [100].
Though these methods have high detection limits, they are time consuming and require
skilled labour and expensive instrumentation. As an alternative, gold aptasensors not only
provide a simple and novel testing tool but also demonstrates high sensitivity and
selectivity towards epinephrine.
Despite having all the aforementioned advantages of using AuNPs-apt based
colorimetric sensors, the biggest challenge which restricts the use of this sensor in real
world application is the low sensitivity compared to other sensing technologies. The
detection limit depends on the morphology of the AuNPs, the binding affinity of the
aptamer, the ratio of the aptamer to the AuNPs and the affinity of the aptamer with respect
to analyte. The shape, size and the dielectric medium surrounding the particles can be
tuned such that even small amounts of analyte can trigger maximum aggregation/color
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change. Along with nanospheres, various shapes such as nanorod and nanostars have
been utilized for the development of colorimetric sensors [111-113]. However, there have
been no systematic studies done which compare the effects of different sizes and shapes
of AuNPs and aptamer-AuNPs interaction on the detection limit of a sensor. Therefore,
the present work explored the effect of different parameters that govern the detection
process such as the number of aptamers on the surface of AuNPs, aptamer binding, salt
concentration and physical morphology of AuNPs. The aim is to optimize all these
parameters such that a maximum shift in the spectra and an intense change in color can
be obtained. These optimized parameters have been used to develop a sensitive and
portable paper based sensor for epinephrine, which can be used as a point of care
diagnostic tool.

2.2

Experimental Section
2.2.1 Materials

Both thiol-modified and unmodified aptamers were used in the present study. The 32-mer
aptamers specific for epinephrine were designed and synthesized by BasePairBio
Company (Pearland, TX). Chloroauric acid, trisodium citrate, L-ascorbic acid, tris (2carboxyethyl)

phosphine

(TCEP),

tris

hydrochloride

(Tris

HCl),

ethylenediaminetetraacetic acid (EDTA), phosphine buffered saline tablets, sodium
chloride (NaCl), magnesium chloride (MgCl2) and epinephrine hydrochloride were
purchased from Sigma-Aldrich (St. Louis, MZ). Gold Nanospheres (15 nm, 30 nm, 50 nm)
with concentration of 1 mg/ml and Gold NanoRods (660 nm resonant, 50 OD) stabilized
by negatively charged citrate ions were obtained from Nanocomposix (San Diego, CA).
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Experiments were performed in a DNAse - RNAse free environment using nuclease free
water, tips and vials purchased from Thermofisher (Waltham, MA). Whatmann® filter
paper #1 was obtained from Sigma Aldrich (St. Louis, MZ).

2.2.2 Instrumentation
Surface charge and hydrodynamic size measurements were performed using Dynamic
Light Scattering (DLS) by Zetasizer, Malvern Instrument equipped with 633 nm He-Ne
laser and a backscatter detector at an angle of 173 degrees. Folded capillary tubes were
used for measuring Zeta potential at a controlled temperature of 25°C and a fixed voltage
of 150 V. The Z-average size was calculated using the “General purpose” analysis model
as provided by the Zetasizer software. For each sample, minimum of 3 measurements
containing 11 runs of duration 10 seconds was performed. The results for the three
readings were averaged and standard deviation was calculated to define the error bars
on the DLS graphs. UV-Vis spectroscopy was performed using FLUOstar Omega plate
reader to determine the absorbance spectrum in the range of 400-800 nm. UV transparent
96-well plates were used for the entire study. AuNPs based on their physical
morphologies exhibit different absorbance peaks in the UV-spectrum. The size and
morphology studies were also done using Philip (FEI Tecnai F30) high resolution
transmission electron microscope (HRTEM) operating at 300 keV. The samples for TEM
were prepared by dip-coating the carbon coated TEM grid in a diluted solution of the
particles and drying it at room temperature. The steps were repeated multiple times to
ensure enough AuNPs are present on the grid. The samples were stored under high
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vacuum overnight to remove any moisture and protect the sample from oxidation. The
average size of the particles was calculated by using Gatan Digital Micrograph software.

2.2.3 AuNPs Synthesis
AuNPs were synthesized using the standard citrate reduction procedure as reported in
the literature previously [114]. Briefly, 100 mL of 1 mM HAuCl4 was heated to boil under
constant stirring. Next, trisodium citrate solution (2 mL, 194 mM) was added rapidly in the
stirring solution resulting in a change in solution color from pale yellow to red. The solution
was boiled for another 20 min and then allowed to cool at room temperature. The solution
was then filtered using 0.22 µm membrane filter to ensure the monodispersivity of the
AuNPs and stored at 4°C for long term stability. The concentration was calculated as 14.4
nM with the help of Beer’s law by using the extinction coefficient of 2.01 x 10 8 M-1cm-1
[115]. The entire scheme is shown in Figure 7.

2.2.4 Preparation of AuNPs conjugated with aptamers
The aptamers were received in a dried pelleted form and were resuspended in TE buffer
(10 mM Tris HCl, 0.1 mM EDTA, pH 7.5) to achieve a concentration of 100 µM. The
solution was aliquoted into smaller volumes to avoid multiple freeze and thaw cycles.
Before immobilization of the aptamers over the AuNPs surface, the aptamers were diluted
to the required concentration using folding buffer (1 mM MgCl2 and 0.01 M PBS, pH 7.5).
The aptamers were brought into a folded state by incubating at 95°C for 5 min and another
15 min at room temperature. The thiolated aptamers were then reduced by using TCEP
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in 1:1 v/v dilution. The addition of TECP ensures the breakage of any disulphide bonds (S-S-) such that free –SH group is available to bind to the gold surface. The reaction was
incubated for 20 min at room temperature. The unmodified aptamers did not require any
reduction steps. AuNPs-aptamer complexes were prepared by mixing the AuNPs and
folded aptamers in 1:1 v/v ratio and kept at room temperature for another hour. Excess
aptamers were washed away by centrifugation at 14,000 rcf for 11 min and resuspending
the conjugates in folding buffer.

Figure 7: Schematic of AuNPs synthesis using seedless approach

2.2.5 Preparation of hydrophobic Paper substrate
Paper based substrates made up of cellulose, such as Whatman® filter paper are
portable, easy to store, readily available and provide high surface area for colorimetric
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bioassays. The surface and pore size of the Whatman® filter paper can be easily
functionalized and controlled by various chemical treatments as per requirement [116118]. In the present study, Whatman® filter paper was cut into strips and functionalized
with wax by directly rubbing the solid wax over the paper. The paper was incubated for
about an hour at 60°C such that the wax spread evenly on the paper surface and seeped
through the pores of the paper. The wax provides hydrophobic nature to the paper which
does not allow AuNPs to wet the surface or spread on to the surface of paper [68].

2.2.6 Colorimetric assays
25 µl of epinephrine at different concentrations was added to 50 µl of AuNPs-apt solution
for each colorimetric assay in the 96 well-plate. The amounts and concentrations of
epinephrine used in the study were 2 µg (360 µM), 1 µg (180 µM), 500 ng (90 µM), 350
ng (63 µM), 200 ng (36 µM), 125 ng (22 µM), 50 ng (9 µM) and so on. The AuNPs-apt
and epinephrine solution was incubated for 10 min at room temperature before performing
the UV-visible spectroscopy. For the different size and shape study, the concentrations
of the different AuNPs were kept constant at 0.2 mg/ml for an accurate comparison of the
detection limit. Each assay was performed at least in triplicate and the data is represented
as mean ± standard errors.

2.3

Results and Discussions

2.3.1 AuNPs Characterization
Figure 8 shows detailed characterization of the as-synthesized (13 nm spherical
particles) and purchased AuNPs. AuNPs (13 nm) were synthesized using the standard
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procedure of citrate reduction of HAuCl4 as shown in Figure 7. The hydrodynamic radii
of the gold colloids are 18.15 nm, 20.10 nm, 36.48 nm, 52.47 nm and 55.91 nm as
measured with DLS instrument and it can be seen that all the particles are in a very narrow
range with minimum/no agglomeration (Figure 8A). Zeta potential results (Figure 8B)
indicate that the citrate coated particles are negatively charged with surface charge as 21.9 mV, -28.33 mV, -37.8 mV, -52.2 mV -52.5 mV and -43.9 mV and this charge
increases with respect to the size of the particles. The negative charge of AuNPs induces
stability in the solution and prevents unwanted agglomeration. AuNPs of diameter 13 nm,
15 nm, 30 nm and 50 nm stabilized in water exhibited distinctive peaks (surface plasmon
band, SPR) at around 518 nm, 520 nm, 524 nm and 528 nm respectively (Figure 8C).
The SPR of the AuNPs is modified when the shape deviates from spherical geometry
[119]. In the case of rods, the electrons are found to oscillate in the transverse as well as
longitudinal direction. The transverse mode showed a resonance peak at approximately
520 nm whereas the longitudinal direction peak was observed at 670 nm (Figure 8D).
Nanourchin shaped particles exhibited a broad, shifted peak at ~562 nm due to the
presence of spikes which results in complex localized surface plasmon resonance
(LSPR). Different absorption peaks of these particles cause changes in their visible color
(Figure 8D).
High resolution transmission electron microscopy (HRTEM) images of the as
prepared and purchased nanoparticles are shown in Figure 9 (A-F). HRTEM images
revealed that particles are uniformly dispersed and have spherical, spiky and rod-like
morphologies. The average sizes are in order of 12.74 nm, 14.66 nm, 27.77 nm, 48.71
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nm, 53.76 nm and 45.34 nm (Table 1). The next section discusses the effect of aptamer
concentration as well as the binding mechanism on the aggregation of the AuNPs.

Table 1: Summary of the properties of gold nanoparticles as characterized through
various techniques.

Gold

Zeta potential

SPR band

Hydrodynamic

TEM average

Nanoparticles

(mV)

(nm)

Size (nm)

size (nm)

Sphere-13 nm

-21.9

518

18.15 ± 2.1

12.74 ± 0.5

Sphere-15 nm

-28.33

520

20.10 ± 0.6

14.66 ± 0.3

Sphere-30 nm

-37.8

524

36.48 ± 0.3

27.77 ± 1.2

Sphere-50 nm

-52.2

528

52.47 ± 0.4

48.71 ± 2.5

Nanourchin

-52.5

562

55.91 ± 0.4

53.76 ± 6.3

Nano Rods

-43.9

520, 620

-

45.34 ± 0.4
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Figure 8: Thorough characterization of different kind of AuNPs. (A) Dynamic Light
scattering measurements showing the diameter of the spherical particles as well as
nanourchins. The mean sizes observed are 18.15 nm, 20.10 nm, 36.48 nm, 52.47 nm
and 55.91 nm respectively. (B) Surface zeta potential of the given samples shows the
presence of negative charge with a small error bar. (C) Normalized UV-visible spectra of
the spherical particles with SPR bands at 518 nm, 520 nm, 524 nm and 528 nm. (D)
UV-Visible spectra of different shapes of AuNPs. The maxima was observed at 518 nm,
562 nm for spheres and urchins where as for rods, these were 520 nm and 670 nm. The
inset shows the visible color of different shapes- Spheres (red), Rods (Green) and
Nanourchins (Purple).
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Figure 9: High Resolution Transmission Electron Microscope analysis for different sizes
and shapes of gold nanoparticles. (A-F) images show the TEM for 13 nm, 15 nm, 30
nm, 50 nm, Nanourchins and Nano Rods respectively. The length is calculated using
Digital Micrograph software provided by Gatan.
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Figure 10: Visible color change in the solution of AuNPs conjugated with different
concentration of thiolated aptamers (0.02 nM to 2 µM) in presence of Epinephrine. The
change in color represents aggregation in the solution. The AuNPs started aggregating
when the aptamer concentration was 20 nM or less and minimum concentration of
epinephrine was 200 ng.

2.3.2 Effect of Aptamer Concentration
13 nm AuNPs were conjugated with different concentrations of the epinephrine-binding
aptamer (2 µM, 200 nM, 20 nM, 2 nM, 0.2 nM and 0.02 nM) and tested against a range
of concentrations of epinephrine (2 µg (360 µM), (1 µg (180 µM), 500 ng (90 µM), 350 ng
(63 µM), 200 ng (36 µM) and 50 ng (9 µM)). Figure 10 shows the visual color change at
different aptamer concentration in the presence of epinephrine and the corresponding
UV-Visible spectra of these samples is represented in Figure 11. The destabilization of
the charge causes aggregation in the solution which can be seen from the TEM analysis
as shown in Figure 12.
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The change in color was observed in solutions starting from 200 ng of epinephrine
and aptamer concentration ranging from 0.02 nM-20 nM. It was observed that the SPR
of AuNPs at 520 nm broadens and shifts to a longer wavelength as a function of the
epinephrine concentration. The degree of aggregation is represented in terms of A 640/A518
where A640 and A518 indicate the absorbance intensity at 640 nm and 518 nm, respectively.
Figure 13 demonstrates a comparative analysis of different samples. It can be seen that
the increase in aptamer concentration (20 nM, 200 nM and 2 µM) decreases the detection
limit of the AuNPs–apt system. There was no aggregation observed in the 2 µM aptamer
solution at any epinephrine concentration.
This result of decreased detection with increased aptamer concentration is due to
the fact that as epinephrine is introduced into the solution, the free unbound aptamer
binds to it [120]. Since the epinephrine molecule is very small in size (Molecular Weight:
219.67 Da), the aptamer wraps around the molecule, making it very difficult for the
molecule to interact with the other aptamers present on the gold surface, thus inhibiting
aggregation of the AuNPs. Also, the conjugated aptamers add to the overall negative
charge of the AuNPs, enhancing the stability of the AuNPs by increasing the electrostatic
repulsion between the particles [121, 122]. It can be observed that the optimized range
of aptamer for maximum detection of the analyte is below 20 nM aptamer concentration
which can detect epinephrine levels as low as 200 ng. At lower concentration of aptamers,
a linear increase in the ratio was observed at 50 ng , 200 ng and 350 ng of epinephrine
which becomes constant at higher concentrations of epinephrine. 2 nM aptamer
concentration gave the maximum A640/A518 ratio which suggest that it is the optimum
aptamer concentration at which maximum aggregation was seen in the solution at 200 ng
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of epinephrine. Higher concentration of aptamer induces excess stability in the solution
as discussed previously. The aptamer concentration lower than 2 nM i.e. 0.2 nM and 0.02
nM is insufficiently low in number and in the presence of low concentration of the
epinephrine molecule, not enough aptamers are present to induce aggregation in the
AuNPs solution. Therefore, AuNPs are conjugated with 2 nM aptamer concentration for
further experiments. The aptamers can be physically adsorbed [122] on the surface of
AuNPs or can bind to the surface of AuNPs via covalent bonding [123, 124]. The following
experiment compares the two different types of the aptamers and studies their effect on
the aggregation.
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Figure 11: UV-Vis spectra of AuNPs conjugated with different concentration of thiolated
aptamers (0.02 nM to 2 µM) in the presence of Epinephrine (50 ng- 2µg). The
experiment demonstrates the effect of aptamer and analyte concentration on the
aggregation of AuNPs. (A) 2 µM aptamer concentration causes the gold nanoparticles
to be very stable and excess of aptamer in the solution binds to the Epinephrine
inhinbiting aggregation in the solution. Therefore, no red shift was observed. (B) A slight
shift in the peak at 640 nm was seen in the presence of 2 µg and 1 µg of Epinephrine
when the aptamer is 200 nM. (C, D, E) Similar response was seen for 20 nM, 2nM and
0.2 nM aptamer concentration with an intense shift in the peak at 640 nm. Minimum
amount of Epinephrine detected was 200 ng. At 50 ng, the Epinpehirne concentration is
too low to induce any aggregation in the solution.
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Figure 12: High Resolution Transmission Electron microscope image for (A) uniformly
dispersed AuNPs and (B) aggregated AuNPs in the presence of Epinephrine. Inset
showing higher magnification with a scale bar of 20 nm.
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Figure 13: Comparative analysis of the A640/A518 ratio as derived from UV-Visible
spectroscopy analysis of samples containing different amount of aptamers (2 µM, 200
nM, 20 nM, 2 nM, 0.2 nM and 0.02 nM) as a function of epinephrine concentration
represented in logarithmic scale (2 µg (360 µM), (1 µg (180 µM), 500 ng (90 µM), 350
ng (63 µM), 200 ng (36 µM) and 50 ng (9 µM)). The increase in the ratio is in
correspondence with the color change in the solution. Solution with 2 nM concentration
(green curve) shows the most significant increase in the ratio at 200 ng of Epinephrine
which indicates maximum aggregation in the solution.

2.3.3 Effect of thiolated and non-thiolated aptamer conjugation
Aptamers can bind to the surface via covalent bond (Au-thiol interactions) [123, 124] or
it can be adsorbed on the surface via electrostatic interactions [122]. Figure 14
represents the comparison between the thiolated and non-thiolated epinephrine aptamer
and its effect on the sensitivity of the aptasensor. As it was observed earlier that 200 ng
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of epinephrine induced intense color change in the solution and red-shift in the UV
spectrum, the AuNPs-aptamers were now tested against 125 ng of epinephrine. It can be
seen from Figure 15 (A, B, C), 125 ng induced slight color change in the solutions in the
presence of aptamer ranging from 20 nM-0.02 nM. However, the UV-Visible data (Figure
15) shows the highest peak at 640 nm which belonged to 2 nM aptamer. The maximum
A640/A518 ratio was achieved for 2 nM of the thiolated aptamer as shown in Figure 14. The
thiolated and non-thiolated produced similar results in terms of color change but UVvisible data showed that the thiolated aptamers are more efficient in detecting the analyte.
The variation in detection of analyte by thiolated versus non-thiolated aptamers is
due to differences in the underlying mechanisms of these two approaches. Thiolated
aptamers bind strongly to the surface of the gold and when the analyte approaches,
AuNPs are pulled together strongly to form aggregates [125]. The repulsion between the
citrate capped AuNPs is dominated by the affinity of aptamers towards the analyte. The
presence of epinephrine bound with the aptamers causes destabilization in the charge of
AuNPs which results in aggregation/color change. On the other hand, the unmodified
aptamers are loosely attached to the AuNPs surface. In the presence of epinephrine, the
aptamers attain a tertiary folded conformation and detach themselves from the surface,
leaving the AuNPs destabilized [122, 126]. The extent of destabilization depends on the
concentration of analyte and the number of aptamers detached from the surface. The
lesser shift in the peak at ~640 nm in the presence of unmodified aptamers is due to
aptamers remaining attached to the surface of AuNPs and screening them from
aggregation. However, the difference is very minor, and therefore, it can be concluded
that both thiolated and non-thiolated aptamers behave almost the same for low
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epinephrine concentrations. Moving forward, thiolated aptamers were used at 2 nM
concentration for testing the effect of AuNPs physical morphology on the detection of
epinephrine.
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Figure 14: Comparative analysis of thiolated and non-thiolated aptamer on the surface
of AuNPs in the presence of 125 ng of Epinephrine. The absorbance ratio (A 640/A518) as
calculated by UV-visible spectra represents maximum aggregation in 2nM thiolated
aptamer solution. The columns represent the mean value and the error bars indicate the
standard deviation in the experiments.
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Figure 15: Comparative analysis of thiolated and non-thiolated aptamer at the surface of
AuNPs on the sensitivity of the aptasensor. (A) UV-visible spectra for the AuNPs
conjugated with thiolated aptamer. The peak for 2 nM aptamer has shown maximum
intensity at 640 nm as compared to other concentrations of the aptamer. (B) UV-Visible
spectra for the non thiolated aptamers. (C) Visible color as observed immediately after
addition of Epinephrine did not show much color change as noticeable by the naked
eyes.

2.3.4 Effect of Different Sizes
So far, the effect of aptamer concentration and the thiolated and non-thiolated binding of
the aptamers has been discussed. 2 nM thiolated aptamer showed maximum sensitivity
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and visible color change towards 125 ng of epinephrine with a maximum peak intensity
at 640 nm. Different sizes of spherical gold nanoparticles (13 nm, 15 nm, 30 nm and 50
nm) have been used to test the limit of detection of the aptasensor. Figure 16 (A, B)
shows the response of different sizes of AuNPs in the presence of 125 ng and 200 ng of
epinephrine. The UV-Visible spectrum shows that the 13 nm AuNPs (black curve)
exhibited a greater red shift in the presence of 125 ng and 200 ng epinephrine compared
to other particles. No shift was seen for 30 nm and 50 nm AuNPs. The derived absorbance
ratio (A640/A518) from the UV-Visible spectra (Figure 16 C) confirms that the maximum
aggregation was observed for 13 nm particles, followed by 15 nm particles with little to no
shift for 30 nm and 50 nm AuNPs. 13 nm AuNPs also exhibited the maximum color
change for all tested concentration of epinephrine (Figure 17).
The strongly bound citrate group induces negative charge on the surface of the
AuNPs which leads to repulsion between the particles [127]. Since the 50 nm AuNPs
have the maximum negative surface charge (Table 1), very little aggregation was
observed in the solution. Because larger sized particles are bulkier than smaller ones,
higher concentrations of analyte are required for the aptamers to agglomerate the
particles. The combined effect of the negative zeta potential as well as the interaction of
aptamer and analyte is responsible for no color change in larger particles.
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Figure 16: Size dependent study for the detection of Epinephrine. (A, B) UV-Visible
spectra showing aggregation in the solution of different sizes (13 nm, 15 nm, 30 nm and
50 nm) of AuNPs at 125 ng and 200 ng of epinephrine. (C) Plot showing trend for the
derived absorbance ratio (A640/A518) for different sized particles. 13 nm particles showed
maximum aggregation in presence of 200 ng and 125 ng of Epinephrine.
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Figure 17: Visible color change in the solution of different sized AuNPs-aptamer (13 nm,
15 nm, 30 nm, 50 nm) in the presence of different concentration of Epinephrine (50 ng,
125 ng, 200 ng). (A) without salt (B) In the presence of salt (170 mM, 10 µl). Maximum
color change can be observed for 200 ng for 13 nm AuNPs particles.

37

2.3.5 Effect of different shapes: Rods, spheres and urchins
Anisotropic nanomaterials with highly complex structures have generated wide spread
interest owing to their enhanced physical and optical properties. In the present section, a
comparative analysis of different shapes of AuNPs used for the detection of epinephrine
has been carried out and the basic characterization is shown in Figure 8 and 9. The
aptamer conjugation process and the concentration of all AuNPs was kept constant as
used for the spherical particles. Figure 18 (A-D) summarizes the result of the assay. The
UV-visible spectra showed an intense red shift in the peak of spherical particles (Figure
18 A). The maximum shift was seen by addition of 500 ng of epinephrine followed by 250
ng and 125 ng. The color change is also in line with the UV shift with maximum change
caused by adding 500 ng of epinephrine. In the case of rods, there was no shift in the
peaks or change in color. The intensity at peak 670 nm showed a constant decrease with
respect to the epinephrine concentration and a very slight shift towards a lower
wavelength. In rods, the red or blue shift is a result of change in the aspect ratio. The
slight blue shift is due to the decrease in the aspect ratio which indicates that some of the
rods have aggregated due to epinephrine. However, there was no change in color
observed for the rods. Nanourchins on the other hand showed no change in the UV-visible
spectra or visible color following the addition of epinephrine. As observed earlier, bigger
size and greater negative charge leads to stability of the particles and lowers the detection
limit. The rods and urchins both have sizes in the range of 50 nm and the zeta potential
is also higher as compared to 13 nm spherical particles (Table 1). Also, the aggregation
behavior of the rods and spheres are different from each other. Nanorods are more stable
than the spherical particles as nanorods are known to possess steric hindrance which
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causes low packing density and smaller aggregates [128-130]. The spheres and urchins
both have higher curvature, thus higher packing density; however, the spiky structure
disrupts aggregation of urchins. Therefore, spherical particles with size between 13-15
nm are the most suitable particles for the colorimetric sensor.
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Figure 18: Detection of Epinephrine using different shapes of AuNPs. Fig. A, B and C
represents the change in UV visible spectra in presence of 13 nm spherical AuNPs,
Gold nanorods and 50 nm Nano urchin. Spherical particles show clear red shift at 500,
250 and 125 ng of Epinephrine whereas in case rods and nanourchin, very slight
change in the intensity of the peaks can be seen. The color change as shown in Figure
D is prominent for spherical particles whereas no color change was observed for Rods
and Urchin.
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2.3.6 Selectivity of the sensor
The specificity of the present colorimetric sensor was tested by using common interfering
agents such as 3, 4-dihydroxyphenylacetic acid (DOPAC), ascorbic acid, tryptophan,
homovanillic acid (HVA), tyrosine, glycine and bovine serum albumin (BSA). 900 µM of
control samples were tested against 90 µM (500 ng) epinephrine to test the specificity of
AuNPs-apt. Maximum shift in UV-spectroscopy is obtained by the addition of epinephrine,
with very little shift being induced by dopamine and no shift by other controls (Figure 19).
These results demonstrate the high specificity of this colorimetric biosensor against
epinephrine.

2.3.7 Aggregation Study-Time based study
The aggregation kinetics was studied by examining the rate of aggregation with respect
to the analyte concentration. Two different concentrations of epinephrine (200 ng and 125
ng) were used to induce aggregation in the solution and the size of the aggregates was
calculated using DLS. 200 ng of epinephrine induced immediate aggregation in the
solution. The change in size in the presence of 200 ng and 125 ng of epinephrine at
different time intervals (0 min, 10 min, 30 min, 1 hour, 2 hours and 3 hours) is shown in
Figure 20. It can be seen that in presence of 200 ng of epinephrine, the solution started
showing an increase in size immediately with the initial size of 21.38 nm as compared to
the 18.16 nm of 125 ng epinephrine. A gradual increase in size can be observed for 200
ng of epinephrine; however, no change in size of AuNPs-apt was observed in the
presence of 125 ng for almost half an hour (Figure 20). After 1 hour, the size increased
from 18.16 nm to 31.21 nm. For both samples, the size remained constant after 2 hours.
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This is in compliance with the established studies in the literature which suggest that this
is due to the completion of charge transfer and stabilization of the aggregates [127]. When
the interparticle distance is greater than the average radius of the particles, the particles
are uniformly dispersed in the solution and emits red color whereas when the interparticle
distance is less than the average radius, the solution starts changing to blue color. After
24 hours, the aggregated particles precipitated in the plate and showed no further
increase in size.
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900 µM concentration of interfering agents such as BSA, Ascorbic acid, Tryptophan,
HVA, Tyrosine, Glycine, DOPAC and Dopamine. Epinephrine (500 ng) caused
maximum shift in the UV-Visible spectra. Control represents the sample without any
analyte in the solution.
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2.3.8 Effect of salt
As discussed previously, the surface of the synthesized AuNPs is derivatized with citrate
ligands which provide them stability against aggregation. Increases in salt concentration
increase the ionic strength of a solution which results in screening of this repulsion force
and induction of aggregation/flocculation of AuNPs. When the AuNPs are conjugated with
aptamers, the aptamers protect the surface of the AuNPs against salt induced
aggregation. However, the presence of epinephrine bound to the aptamer decreases the
overall negative charge of the AuNPs and causes destabilization of the apt-AuNPs.
Addition of salt further amplifies the charge destabilization and causes aggregation in
solution.
The present AuNPs-aptamer system was tested against a range of NaCl
concentration and it was observed that 170 mM NaCl induced no shift in the UV spectra
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and was therefore chosen for further experiments. Figure 21A shows the UV-Visible
spectra of the AuNPs-aptamer in the presence of different concentration of epinephrine
after the addition of 170 mM NaCl. There is a clear red shift in the spectra with the
increase in the concentration of epinephrine. The derived absorbance ratio (A640/A518)
increases proportionally from 0.22 to 1.15 with increase in the epinephrine concentration
which corresponds to aggregation in the solution (Figure 21B). The lowest amount of
epinephrine that induced red shift in the spectra was 0.005 ng (0.9 nM) as shown in
Figure 21. In the absence of epinephrine, the aptamers conjugated AuNPs show high
stability against NaCl and no red shift was observed in the UV-Visible spectra. The
present approach with the optimized parameters was then tested on a hydrophobic paper
substrate to formulate an easy-to-use device.
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Figure 21: Effect of addition of salt on the detection limit of the sensor. (A) UV-Visible
spectroscopy showing spectral shift in the presence of difference concentration of
epinephrine ranging from 0.5 pg to 500 ng (0.09 nM to 90 µM) and salt (170 mM).
Addition of salt causes red shift in the spectra in the presence of epinephrine whereas
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no shift was seen for the blank sample (no analyte). (B) The derived absorbance ratio
(A640/A518) increases proportionally with the increase in epinephrine concentration.
Lowest concentration of epinephrine that induced red shift in the UV-Visible spectra is
0.9 nM.

2.4

Paper based sensor

So far, it has been discussed that 13 nm spherical particles when conjugated with 2 nM
thiolated aptamers in the presence of salt showed high detection limit for epinephrine (0.9
nM). The increase in concentration of epinephrine leads to increase in aggregation and
thus increases the intensity of color change as seen from the shift in UV-Visible spectra.
The concentration of AuNPs was varied to study the effect on the detection of
Epinephrine. The AuNPs conjugated with aptamer were concentrated to 2X, 3X and 4X
times by centrifuging at 11500 rcf for 11 min resulting in a concentration of 14 nM, 21 nM
and 28 nM. The results demonstrated that 4X concentration showed the maximum
sensitivity towards epinephrine. As explained earlier, the aggregation depends on the
interparticle distance as well as the radius of the particles. In 4X solution, the number of
AuNPs is four times the original solution in a same volume of the solution. The distance
between each particle decreases, therefore, the probability of aggregation as well as the
intensity of color change also increases with increasing concentration. The AuNPsaptamer based biosensor with all the optimized parameters were then used for the
fabrication of a paper based sensor.
The color change on the paper was calculated quantitatively using the red-greenblue values of each AuNPs spot determined by image processing software (Color helper,
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2013) [131]. The blue/red ratio directly correlates with the degree of aggregation in the
solution and hence the concentration of epinephrine. 10 µl of AuNPs-aptamer was added
on the surface of the paper and different concentrations of epinephrine (9 µM, 4.5 µM,
1.8 µM, 9 µM, 900 nM, 90 nM, 9 nM, 900 fM, 90 fM) were added onto the drop of AuNPs
solution. To enhance the aggregation in the solution, 2 µl of 170 mM NaCl was also added
in all the samples which resulted in immediate color change (Figure 22). The addition of
as low as 9 nM epinephrine began inducing color change in the solution and resulted in
a significant increase in the B/R ratio. The B/R value for AuNPs without aggregation in
the solution was found to be around 0.58 and addition of epinephrine increases this value
to more than 1 which indicates aggregation of AuNPs-apt in solution.
The developed paper based sensor can be used in conditions where plasma
catecholamines reach supraphysiological levels. In patients with stress induced
cardiomyopathy (Takotsubo cardiomyopathy) and Killip Class III myocardial infarction,
epinephrine levels average 6.9 x 10-9 M and 2.1 x 10-9 M after 1 or 2 days, respectively
[132]. Normal physiological serum epinephrine concentration is approximately 0.13 x 10 9

M, which is below the detection limit of the sensor. [100] Therefore, supraphysiological

levels of epinephrine will induce a color shift on the optimized paper sensor detectable
with UV-visible spectroscopy but normal physiological values will not. This supports the
diagnostic use of the sensor in a real-world situation. Furthermore, since the UV-vis shift
is correlated to the concentration of target analyte, this method may also be used as a
quick determinant of epinephrine levels in the patient.
The use of a cellulose-based paper approach provides a simple, easy and
equipment free tool for sensing biomolecules. Of note, the paper did not interfere with the
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sensing mechanism but further enhanced the color variance by providing high contrast
background [68, 133]. The test result was stable for up to 30 min and indicates high
sensitivity for the epinephrine molecule.

Figure 22: Colorimetric analysis of AuNPs-aptamer in the presence of different
concentration of epinephrine (9 µM, 4.5 µM, 1.8 µM, 9 µM, 900 nM, 90 nM, 9 nM, 900
pM, 90 pM) on a hydrophobic paper based substrate. The corresponding ratio of
blue/red colour values of the AuNPs spots are represented in the figure. The columns
represent the mean values whereas the small error bars represent the standard
deviation in the different set of experiments. The change in colour was observed at 9
nM with a significant increase in B/R value from 0.58 to 0.65.
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2.5

Summary

To the best of our knowledge, the present work is the first established colorimetric
detection of epinephrine using an aptamer based approach. The minimum amount of
epinephrine detected using AuNPs-apt system was 9 x 10-9 M on a paper based sensor
and 0.9 x 10-9 M using UV-Visible spectroscopy. While all the parameters tested in this
current study played an important role in the functionality of the paper-based sensor, the
size and morphology of the AuNPs proved most crucial in controlling the detection limit.
It was observed that bigger size particles with greater negative charge are too stable and
therefore not suitable for an efficient sensor. This optimized AuNPs-apt sensor approach
can be used for the detection of any biomolecule so long as the bound aptamer is
designed to detect the target analyte. Successful implementation of this paper-based
sensor will provide easy, rapid, portable and inexpensive point-of-care testing which will
revolutionize the world of bio-diagnostics and bio-imaging.
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CHAPTER 3: HIGHLY SELECTIVE APTAMER BASED ORGANIC
ELECTROCHEMICAL BIOSENSOR WITH PICO-LEVEL DETECTION
The work presented in this chapter has been published in

Biosensors and Bioelectronics 117 (2018) 40–46; DOI: 10.1016/j.bios.2018.05.031
Reproduced by permission of Elsevier

3.1

Introduction

Organic electrochemical transistors (OECTs) show great potential in the field of
biosensors due to their low operating voltages and signal amplification. Over the past 30
years, OECTs have been utilized to detect numerous metal ions [134], small biomolecules
[135, 136], proteins [137], oligonucleotides [138] and many other biological reagents [139142]. The cost effectiveness, availability, simplicity and portability of OECTs give them an
edge over other traditional optical techniques used as biosensors in diagnosis [143]. The
OECT device based on PEDOT: PSS (poly(3,4-ethylenedioxythiophene) polystyrene
sulfonate) has shown a higher transconductance as compared to silicon based transistor
and also outperformed electrolyte-gated graphene [144, 145]. PEDOT: PSS based
OECTs offer a means of developing highly efficient point-of-care testing tool which exhibit
high sensitivity and selectivity for the detection of molecule of interest.
A typical OECT device consists of a source-drain channel which is connected by
an organic semiconducting material such as PEDOT: PSS as an active layer. The device
can be switched on or off by varying the channel current that flows through the active
layer controlled by an applied voltage from the third electrode called gate [146]. The
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effective gate voltage depends on the potential difference between the PEDOT:
PSS/electrolyte and gate/electrolyte interface. The conductivity of the active layer can be
modulated through doping/de-doping effects of the electrochemical reactions occurring in
the device [147]. Therefore, any charge transfer reaction which alters the surface potential
of the gate electrode causes a significant change in channel current which can be
measured with high accuracy using simple instrumentation [148]. The transducing
properties along with high specificity in these devices make them excellent candidate in
biosensing especially in healthcare industry where detection at an early stage can be
extremely helpful.
The application of OECT device as a biosensor [134-142] relies on the use of some
biorecognition element such as enzymes, antibodies, oligonucleotides etc. which can
transduce an electrochemical change in the presence of molecule of interest. Aptamers
have been extensively used as the biorecognition molecule in the field of colorimetric
[149], [122], electrochemical [150], spectrophotometry [151], [152], mass-sensitive [153],
and electrophoretic sensing [154], [155]. Aptamers are short DNA or RNA chains which
selectively bind to a target molecule with high affinity. As compared to antibodies and
enzymes, aptamers are resilient to heat, pH variation and chemically harsh conditions
which makes them more efficient for practical applications [137]. The process of SELEX
(Systematic Evolution of Ligands by Exponential Enrichment) is used to design and select
appropriate aptamers for the target molecules [138]. Once the aptamers are designed,
these can be synthesized in large quantities with high purity and reproducibility [153].
Thus, the use of aptamers offers a method for sensitive, selective, and affordable
biomolecule detection.
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In this study, an ultra-sensitive label free aptamer based OECT device has been
developed to detect the presence of catecholamine epinephrine. Epinephrine, commonly
known as Adrenaline, is responsible to prepare the body for “fight or flight” response by
accelerating the heartbeat, stimulate glucose production [156], dilate pupil [157] etc. It is
generally administered in case of severe emergency situations such as cardiac attack,
anaphylactic shocks or asthma attacks. The physiological level of epinephrine in a human
body under normal conditions ranges form 120-200 pM [158] which shoots up in
conditions like pulmonary edema [159], Takotsubo cardiomyopathy [160], myocardial
infarction [161], arrhythmias [162] and other thyroid problems [158]. Therefore, detection
of epineprhine has significance in a variety of applications ranging from severe allergy
reactions, anti-doping regulations to treatments for cardiac attacks. The detetction of such
small molecules has been done using various spectroscopic and chromatographic
techniques [104, 149, 163-168] which has given impressive results, however these
techniques are generally time consuming, complex and require skilled labour. The
present approach introduces a highly efficient sensor providing a means for real-time
detection in a timely and efficient manner and requires very small volume of the sample
to run.
Figure 23A illustrates the aptamer based OECT device fabricated for the detection
of epinephrine molecule in the present study. The gate, source, and drain electrodes are
labelled as 1, 2, and 3 respectively. The source and drain electrodes are bridged by an
organic semiconductor layer PEDOT: PSS, shown by the translucent, dark blue rectangle.
The epinephrine specific aptamers are immobilized on to the gate electrode by thiol
bonding. A PDMS mold is used to contain the electrolyte solution which ensures direct
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flow of current between the aptamer modified part of the gate (labelled as 4) and the
PEDOT: PSS layer. The working principle of the current approach is based on the
interaction of aptamers with epinephrine which enables the oxidation of the molecule in
the vicinity of gate electrode. The oxidation generates 2e - in the solution which produces
Faradaic current in the device. The screening of the negative charge of aptamers along
with the production of Faradaic current results in an increase in the effective gate voltage
and decrease in the overall channel current which is measured as output signal. The
present approach leads to a highly sensitive and specific label-free sensor which exhibits
time and cost effectiveness, easy readout signals and utilizes off-the-shelf electronics.

3.2

Methods & Materials

3.2.1

Chemical Reagents

Epinephrine binding thiolated 32-mer aptamers were synthesized and provided by
BasePairBio Company (Pearland, TX). Chemicals such as epinephrine, 3,4dihydroxyphenylacetic acid (DOPAC), tyrosine, glycine, dopamine, cysteine, L-ascorbic
acid, tryptophan, PEDOT: PSS, and DMSO (dimethylsulfoxide) used during testing were
purchased from Sigma-Aldrich (St. Louis, MZ). The TCEP (Tris (2-carboxyethyl)
phosphine), Tris hydrochloride, phosphate buffered saline, and magnesium chloride that
were utilized to make folding and resuspension buffers were also purchased from SigmaAldrich (St. Louis, MZ). LOR, Shipley microposit S1813, MF-CD-26 developer, and PG
remover used for photolithography and pattering of the electrodes were purchased from
Microchem (Westborough, MA). Gold pellets for deposition of gold electrodes were
obtained from Kurt J. Lesker Company (Jefferson Hills, PA). The silicon wafers with
51

orientation (100) were purchased from Wafer World Inc. (West Palm Beach, FL). For all
experiments in the study, DNAse – RNAse free tips, vials and water purchased from
Thermofisher (Waltham, MA), were used to avoid nuclease contamination.

3.2.2 Fabrication and measurement of OECT- based sensor
The OECT device used in the present study (Figure 23A) was constructed on silicon
wafer. First, the wafer was cleaned by rinsing with acetone, isopropanol, and water. The
wafer was dried by using nitrogen followed by a 30 second bake at 120°C. To begin the
fabrication process, the wafer was coated with a 10 nm thick aluminum oxide layer by
using an Atomic layer deposition system. The deposition rate was kept at 0.1 nm per
cycle for a total of 100 cycles at 150°C. The aluminum oxide layer ensured electrical
insulation of the silicon.
The following photolithography steps were conducted in a clean room:
A.

The wafer was coated with LOR by spin coating at 3000 rpm for 50 seconds

followed by a 5 min bake at 175°C.
B.

After cooling, the wafer was coated with Shipley S1813 by spin coating at 5000

rpm for 50 seconds followed by a 2 min bake at 120°C.
C.

The wafer was then exposed to UV at a wavelength of 275 nm for 20 seconds

under a mask which was used to pattern the electrode onto the wafer.
D.

After another bake for 2 minutes at 120°C, the wafer was developed in MF-CD-26

developer for 1 minute with constant agitation.
E.

Finally, the wafer was rinsed with deionized water, blow dried with nitrogen and

baked for 30 seconds at 120°C.
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F.

To deposit gold, an AJA e-beam evaporator was used. First, 3 nm layer of titanium

was deposited to enhance the adhesion of the gold to the silicon wafer. Then, 50 nm layer
of gold was deposited. After deposition, LOR, Shipley, and unwanted sections of gold
were removed by ultrasonicating the wafer in PG remover for 20 minutes.
G.

The end result left gold deposited only on the sections patterned by UV exposure,

creating the gold electrodes for OECT. The entire channel length and the width of the
electrodes were 2.6 cm and 0.5 cm respectively. The diameter of the gate electrode was
kept at 0.4 cm.

3.2.3 PEDOT: PSS deposition
The PEDOT: PSS layer was deposited using a similar protocol as gold deposition. After
the transistor fabrication process, the transistor was rinsed with acetone, isopropanol, and
water, and then properly dried. Shipley microposit S1813 was deposited by spin coating
at 5000 rpm for 50 seconds followed by a 2 min bake at 120°C. Again, UV exposure for
20 seconds was used for patterning, but a different mask was used which only patterned
the junction between the source and drain electrodes. The wafers were developed in MFCD-26 developer for 1 minute with constant agitation. The wafer was rinsed with
deionized water, blow dried with nitrogen and baked for 30 seconds at 120°C.
The active layer of PEDOT: PSS was deposited using the same photolithography
protocol. The solution of PEDOT: PSS was first filtered using a 0.22 µm membrane filter
and modified with the addition of 5% by volume DMSO to decrease its solubility in
aqueous solutions and increase its conductivity [169]. The filtered solution was spin
coated onto the patterned wafer, followed by baking at 120°C for 40 minutes. The result
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was a thin, translucent layer of the active material deposited at the junction of the channel.
The thickness of the layer as measured using Dektak Profilometer was around ~200 nm.
The optimization of PEDOT: PSS deposition for uniform thickness, surface area and
shape ensured consistent electrical and physical properties and less variability between
different samples.

3.2.4 Aptamer Preparation and Immobilization
The lyophilized epinephrine binding aptamers were dissolved in suspension buffer (TE
buffer, 0.1 mM EDTA, 10 mM Tris HCl, pH 7.5) to achieve a concentration of 100 µM.
The aptamers were then aliquoted into smaller volumes and stored at -20°C for long term
storage. To prepare the aptamers for conjugation, a standard protocol of folding and
reducing steps was followed. The aptamers were diluted using the folding buffer (1 mM
MgCl2 and 0.01 M PBS, pH 7.5) to acquire the working concentration and incubated for 5
min at 95°C. The aptamers were then allowed to cool at room temperature for 15 min so
that they can attain their folded conformation which enables binding to the analyte
molecule. Before immobilization the aptamers were reduced using TCEP which cleaves
the disulphide bonds and forms sulfhydryl group which is used for attachment to the gold
surface. 10 µL of 10 µM reduced aptamers were applied to the gate electrode and allowed
to incubate for 2 hours at room temperature. The excess aptamer solution was removed
and the gate electrode was washed multiple times with PBS to remove any unbound
aptamers from the surface.
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Figure 23: (A) Schematic illustration of the fabricated aptamer based OECT device on a
silicon wafer. The source, drain and gate electrodes are labelled as 1, 2 and 3
respectively. Organic semiconducting layer of PEDOT: PSS is used as an active layer
to bridge the channel and is represented by blue translucent rectangle. The magnified
image of the gate electrode shows the immobilization of aptamers with help of thiol
bonding. Further, the formation of epinephrine-aptamer complex upon addition of the
epinephrine and the oxidation of epinephrine on the aptamer modified gate electrode
has been shown. (B): Output characteristics (ID vs VD) of the aptamer based OECT
device measured in pure PBS solution in the absence of epinephrine at V G values of 0,
0.2, 0.4, 0.6, 0.8 and 1.0 V (from top to bottom). (C): Transfer characteristics (ID vs VG)
of the OECT device measured in PBS solution before and after immobilization of the
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aptamers on the gate electrode at VD = +0.1 V. The immobilization of the aptamers
caused a right shift in the VG curve and the difference is measured out to be 46 mV.

3.2.5 Testing Apparatus
The electrical characteristics of the device were studied by a Keysight B2902A Precision
Source and Measurement Unit controlled by EasyEXPERT software. The Keithley source
meter was connected to the electrodes to apply and measure both voltage and current
through the device simultaneously. During testing, a PDMS gel mold was used to contain
the electrolyte solution between the aptamer modified part of the gate electrode and
channel (Figure 23A, labelled as 4). The mold was shaped to ensure that the solution
only contacted the PEDOT: PSS and the aptamer conjugated part of the gate electrode.

3.3

Results

3.3.1 Output characteristics
The output characteristics (Channel current, ID vs source-drain voltage, VD) of the present
OECT device at varying VG from 0 to +1.2 V along with a negative bias at VD is shown in
Figure 23B. ID decreases with the increase in the gate voltage, VG which is a typical
response of PEDOT: PSS based OECT device operating in depletion mode (increase
gate voltage decreases the channel current) [170], [171]. The positive voltage applied at
the gate induces cations from the electrolyte into PEDOT: PSS and compensate for the
negative sulphonate anions present on PSS. This results in de-doping of the
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semiconducting layer causing a decrease in the hole density which in turn decreases the
overall channel current. The de-doping in PEDOT: PSS is reversible in nature and the
layer attains its original state when the gate voltage goes to zero [172].

3.3.2 Aptamer functionalization
The functionalization of gate electrode with aptamers was confirmed by measuring the
absorbance intensity of the applied aptamer solution before and after incubation. A
significant decrease in absorbance intensity at 260 nm (A260) was observed and
quantitative analysis was done by plotting the calibration curve. The packing density for
the attached aptamers was calculated to be 2.2 × 1012 aptamers per cm2. (Figure 24 (A,
B)). The higher packing density of the aptamers hinders the binding of aptamer-analyte
due to the close packing of the strands whereas the lower packing density results in low
performance because of the less binding sites available. The packing density of 2.2 x 10 12
lies near the optimum packing density (1.6 x10 12) as reported in the previous studies [173,
174].
The effect of addition of aptamers over Au gate electrode was also examined
through output characteristics. Figure 23C shows the ID versus VG characteristics at a VD
of +0.1 V. The measurement was done in same electrolyte solution (pure PBS) before
and after functionalization with epinephrine aptamers. A significant increase in channel
current was observed after functionalization of gate electrodes. As reported previously,
the performance of an OECT depends extensively on the surface potential and
electrolyte/gate interface capacitance of the gate electrode [171, 175, 176]. Therefore,
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the immobilization of the aptamers over the gate electrode increased the overall negative
charge density due to the presence of phosphate backbone which resulted in a decrease
in the effective gate voltage and thus increase the overall channel current [138, 177, 178].
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Figure 24: (A) UV-spectra of aptamers at different concentration in PBS solution. (B)
The absorbance at 260 nm (A260) as a function of concentration of aptamers. Washed
aptamers showed an absorbance of 2.4 which corresponds to 6.3 µM concentration.

3.3.3 Transfer characteristics
The transfer characteristics (ID vs VG) were studied at VD= +0.1V by using PBS as the
electrolyte. The aptamers conjugated gate electrode of the device was incubated with
epinephrine solution (90 pM, 900 pM, 9 nM, 90 nM, 900 nM, 9 µM, 90 µM, 900 µM) for 10
min and then washed off to remove unbound epinephrine. Figure 25A shows the channel
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current (ID) vs. gate voltage (VG) transfer curve at various concentrations of epinephrine.
It was found that as the concentration of epinephrine increased from 90 pM to 900 µM,
the transfer curve showed a distinct trend towards lower gate voltage. The change in gate
voltage (∆VG) as a function of concentration of epinephrine (log[Epi]) was plotted with the
help of transfer characteristics (ID vs VG) shown in Figure 25B. The device shows a
constant increase in |ΔVG| with increase in the concentration of epinephrine and a linear
behavior can be seen from 90 pM to 900 nM. The ∆VG becomes constant due to saturation
of aptamer binding sites at higher concentration of epinephrine (>900 nM). The detection
limit of the system was found to be 90 pM which showed a change of 53 mV upon addition
of epinephrine.
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Figure 25:(A) Transfer characteristics (ID vs VG) of the aptamer based OECT device in
the presence of different concentration of epinephrine at VD=+0.1V in PBS solution. A
constant left shift in the VG with increasing amount of the epinephrine can be seen. (B)
The change in VG of the OECT induced by interaction of epinephrine with the aptamers
as derived by the transfer characteristics. The inset shows the fitting of the linear range
(90 pM to 900 nM) having an R2 value of 0.98.
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3.3.4 ID -time characteristics
In order to monitor the real-time response of the aptamer modified OECT device, channel
current, ID vs time curve was plotted at VD= +0.1V and VG= +0.7V as fixed parameters.
The dependence of the source-drain current on the consecutive additions of epinephrine
at various concentrations (90 pM-90 µM) is shown in Figure 26A. It can be seen that the
addition of epinephrine at consecutive time intervals caused constant drops in the current
which was seen almost immediately after the addition. It was also observed that along
with the drop in current, there was slight increase in the channel current before the next
addition. The binding of epinephrine to the aptamer is a dynamic process. The process
includes constant association and dissociation of the molecules which takes a few
seconds to equilibrate so that the system can attain lowest energy state. Therefore,
instead of a straight curve, slight elevations were observed at lower concentrations (90
pM, 900 pM, 9 nM and 900 nM). At higher concentrations, sharp drop in the channel
current was observed after the addition. The change in channel current (|∆ID|) gives a
linear dependence on logarithmic function of concentration of epinephrine as shown in
Figure 26B.

3.3.5 Selectivity Assay Results
To test the selectivity of the aptamer based OECT sensor, an ID vs t test was conducted
to observe the device response to biomolecules other than epinephrine. The interfering
species selected were DOPAC, tryptophan, tyrosine, glycine, cysteine, dopamine, and
ascorbic acid. These species were chosen either due to their structural similarity to
epinephrine, or their similar biological functions. Figure 26C demonstrates device
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response in terms of change in ID with subsequent addition of interfering species at a time
interval of 5 min. The sensor displayed a sharp decrease in ID after the addition of
epinephrine whereas for other reagents, very slight/no change in the current was seen.
1.2

Epinephrine

90pM
pM
90
900
900 pM
pM
nM
99nM

1.0
0.8

0.8
0.7
0.6

90
90nM
nM
900
900nM
nM

µM
9 9µM

ID/I0

(B)
||ΔI
DIDD| |(mA)
(mA)

(A)

0.6

90 µµM
M

0.4

0.5
0.4
0.3
0.2
0.1

0.2

0.0
11

24

37

50

63

76

89

102

-11

10

Time (min)

(C)

1.4

Interfering species

1.2

1

2

3

4

1.0

5

6

V G2

8

0.8

ID/I0

(D)
V G1

7

-10

10

V G3

-9

10

-8

10

-7

10

-6

10

10

-4

10

-3

10

Cc

Cg

(1)

-5

Concentration (M)

(2)
(3)

0.6
0.4
0.2
0.0

0
2

7

12

17

22

27

32

37

42

47

Gate

Time (min)

Electrolyte

Channel

Figure 26: (A) The normalized time-current (ID/I0 versus t) characteristics of the present
OECT device at VD= +0.1 V and VG= +0.7 V as fixed parameters. Addition of
epinephrine was done at subsequent intervals of 13 minutes at a concentration of 90
pM, 900 pM, 9 nM, 90 nM, 900 nM, 9 µM, 90 µM - left to right. The increase in
epinephrine resulted in constant drops in the channel current. (B) The change in
channel current (mA) is plotted as a function of epinephrine concentration (90 pM-90
µM). A linear response was observed in the presence of epinephrine concentration with
R2 value of 0.96. Error bars represent the standard deviation from the mean value. The
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large error bar at 90 µM is due to the saturation of aptamer binding sites. (C) The
normalized current response as a function of time (ID vs t) in the presence of interfering
species (10 µM). The addition was done at an interval of 5 min in the order of DOPAC
(1), tryptophan (2), tyrosine (3), dopamine (4), glycine (5), cysteine (6), ascorbic acid (7)
and epinephrine (8). A sudden drop in the current was seen after the addition of
epinephrine (1 µM). (D) A schematic illustration of the change in VG before and after
addition of epinephrine. To maintain the same effective voltage in the device, the V G
decreases to offset the Faradaic current produced due to the oxidation of epinephrine.
VG1 represents the device with only immobilized aptamers and VG2, VG3 represents the
new gate voltage with increasing concentration of epinephrine respectively. V G1 >VG2 >
VG3.

The concentration of epinephrine used was 1 µM whereas 10 µM for the interfering
species.The addition of cysteine and dopamine caused slight decrease in the current as
can be observed at 22 min and 32 min. Interference from dopamine can be due to high
structural similarity between epinephrine and dopamine. The thiol group present in the
cysteine molecule could have interfered in the output signal as thiol is known to have a
high affinity for the gold surface. Overall, the presence of aptamers suppressed the
nonspecific binding of the interfering species at the gate electrode.

3.4

Discussions

The working of an OECT device depends largely on the change in conductance of the
active layer due to the electrochemical doping/de-doping of the cations from the
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𝑒𝑓𝑓

electrolyte controlled by variation in the effective gate voltage (∆𝑉𝐺
𝑒𝑓𝑓

∆𝑉𝐺

) of the device. The

depends on the potential difference between the gate-aptamer/electrolyte and

PEDOT: PSS/electrolyte. In the present study, the ∆VGeff is dependent only on the change
in the potential at gate-aptamer/electrolyte interface since epinephrine-aptamers complex
are formed on the gate electrode. The channel current of an OCET device at a certain V G
and VD is given by the following equation.
𝑊𝑞𝜇𝑡𝑝0

𝐼𝐷 =

𝐿𝑉𝑃

𝑒𝑓𝑓

(𝑉𝑃 − 𝑉𝐺

+

𝑉𝐷
2

𝑒𝑓𝑓

) 𝑉𝐷 , (𝑤ℎ𝑒𝑛 |𝑉𝐷 | ≪ |𝑉𝑃 − 𝑉𝐺
𝑉𝑃 =

𝑒𝑓𝑓

𝑉𝐺

|)

(1)

𝑞𝑡𝑝0
𝐶𝑖

= 𝑉𝐺 + 𝑉𝑜𝑓𝑓𝑠𝑒𝑡

(2)

where W and L represents the width and length of the channel, t is the thickness of the
organic semiconductor layer (PEDOT: PSS), q is the electronic charge (1.6 x 10 19), μ is
the hole mobility, Ci is the effective gate capacitance and p0 is the initial hole density of
the channel before applying VG. VP is the pinch-off voltage and VD is the source-drain
𝑒𝑓𝑓

voltage. The ∆𝑉𝐺

represents the effective gate voltage in the device and VOffset is the

change in potential due to potential difference between the gate/electrolyte and PEDOT:
PSS/electrolyte interface.
After the binding of epinephrine to the aptamers and application of positive voltage
at the gate electrode, the electro-oxidation of epinephrine occurs. The oxidation causes
release of 2e- in the solution which produces Faradaic current at the gate/electrolyte
interface.
Epinephrine → Epinephrine quinone + 2H+ + 2e-
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As a result, there is a decrease in the potential drop which increases the effective gate
voltage of the device. This change in effective gate voltage further decreases the overall
channel current as given in Equation 1. The change in effective gate voltage due to the
electro-oxidation of epinephrine is given by:
𝑉𝑜𝑓𝑓𝑠𝑒𝑡 =

2.3(1+𝛾)𝑘𝑇
𝑛𝑒

log[𝐸𝑝𝑖] + 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡

(3)

where 𝛾 is defined as the ratio between the capacitances of the channel (C C) and the gate
(CG) with respect to the electrolyte, 𝛾 = CC/CG; n (=2) is the number of electrons released
during the oxidation, k and T represent the Boltzmann constant and room temperature
and log[Epi] is the logarithmic function of concentration of epinephrine. As shown in
Figure 25B, the slope of the fitted curve was found out to be 80 mV/decade in the linear
region and thus the value of 𝛾 was 1.24. The left shift in the ID vs VG curve with increase
in the concentration of epinephrine, [Epi] is occurring due to the change in V Offset value
which is directly proportional to the concentration of epinephrine as given in Equation 3.
At higher concentrations of epinephrine, the VOffset becomes constant as the aptamer
binding sites becomes saturated with epinephrine. The unbound epinephrine molecules
were washed off before measuring the transfer characteristics. Therefore, the present
sensor follows linear dependence on epinephrine concentration in the 90 pm-900 nM
concentration regime.
Figure 26D represents the working of the present OECT device. As discussed
previously, the immobilization of the aptamers introduces negative charge on the gate
electrode which decreases the surface potential. To maintain the same effective voltage
in the device, the VG increases and a shift in the transfer curve to the right side is observed
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(Figure 23C). However, upon the addition of epinephrine, the negative charge is
balanced by the positively charged epinephrine (pKa 8.02), the overall effective gate
voltage increases. To balance this extra potential change, the V G decreases and curve
shifts to left side (Figure 25A). The change in VG showed a linear dependence on the
concentration of the epinephrine molecule in the range of 90 pM to 900 nM after which it
starts saturating. The synergistic effect of the binding event of aptamers along with the
𝑒𝑓𝑓

oxidation of the epinephrine molecule enhances the ∆𝑉𝐺

as a function of concentration

of epinephrine which amplifies the change in current and therefore the sensitivity of the
present OECT device.
The addition of epinephrine on the bare gate electrode (no aptamers) was also
studied with the help of real time ID response curve as shown in Figure 27. The plot shows
no change in the current upon addition of epinephrine at 100 pM, 1 nM, 10 nM until 100
nM when a huge drop in current was observed. The decrease in the current is due to
increased concentration of epinephrine in the electrolyte solution which facilitated the
oxidation of epinephrine. The binding of epinephrine to the aptamers not only changes
the surface potential of the gate electrode but also ensures the accumulation of
epinephrine molecules in the vicinity of the gate electrode. The increased concentration
of epinephrine around gate expedites the oxidation of the molecule and hence, maximizes
the sensitivity of the sensor. Therefore, the presence of aptamers contributes to the high
specificity of the sensor and also increases the detection limit by an order of atleast 103
magnitude.
So far it has been established that the detection limit of the current approach is 90
pM. The physiological level of epinephrine for a healthy individual is in the range of 12065

200 pM which increases in conditions like hyperthyroidism (359 ± 150 pM) and
hypothyroidism (373 ± 150 pM) [158]. The increase in epinephrine level is also prominent
in Takotsubo cardiomyopathy and Killip Class III myocardial infarction which averages
the level to 6.9 nM and 2.1 nM after 1 or 2 days respectively [132]. Quantitative analysis
of epinephrine can be done using the present approach in the range of 90 pM to 900 nM
which can be used for the early detection of pathological conditions as described above.
Table 2 summarizes the different approaches used for the detection of epinephrine and
their respective detection limits as listed in the literature. 2015 Mak et al. study reported
a comparable detection limit of 100 pM [165] . The study is based on the electrical
oxidation of epinephrine molecule using Pt based gate electrode modified with nafion and
single walled carbon nanotube. The interference from ascorbic acid was seen at 100 nM
whereas the present sensor showed no response to ascorbic acid even at a concentration
of 10 µM. Selectivity is essential for real-world sensors to avoid the need for costly and
time-consuming purification steps. Therefore, the aptamer-based OECT sensor
presented in this work exhibits great potential in the real-world applications which gives
fast and easy-to-read signals.
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Figure 27: The normalized time-current (ID/I0 versus t) characteristics of the present
OECT device in the presence of different concentration of epinephrine on bare Au gate
electrode. The addition was done at an interval of 10 min in the order of 100 pM, 1 nM,
10 nM and 100 nM in the presence of PBS as electrolyte. The plot shows no change in
the current upon addition of epinephrine at 100 pM, 1 nM, 10 nM until 100 nM when a
huge drop in current was observed.
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Table 2: Comparison of different techniques used for the detection of epinephrine and
their respective detection limits.

Method

Detection limit

References

Colorimetric

900 pM

[149]

Capillary Electrophoresis

100 nM

[163]

Ion chromatography

5.9 nM

[167]

HPLC-MS

56 nM

[104]

Differential Pulse Voltammetry

90 nM

[168]

Chemiluminescence

1.1 µM

[164]

Differential Pulse Voltammetry

30 nM

[166]

OECT

100 pM

[165]

OECT

90 pM

Present method
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3.5

Summary

A. A PEDOT: PSS based OECT sensor functionalized with aptamers was fabricated to
detect the presence of epinephrine molecule. The high binding affinity of the aptamers
towards epinephrine and the electro-oxidation of the molecule in the vicinity of gate
electrode allow the present aptasensor with 90 pM limit of detection. The addition of
epinephrine on the gate electrode resulted in a significant decrease in the channel current
which was observed in both ID vs VG and ID vs time characteristics. In addition,
experiments were conducted against common interfering agents to determine the
selectivity of the OECT sensor. The device showed an instant drop in current upon
addition of epinephrine as opposed to the other interfering molecules, indicating highly
selective nature of the sensor. The inclusion of aptamers resulted in an increase of
sensitivity by 103 magnitude and high specificity towards epinephrine molecule. The
present approach provides an easy, simple, rapid method for detecting epinephrine,
however more work needs to be done in order to test the repeatability and reusability of
the sensor. The future work will be aimed at extending the current approach to develop
flexible sensor capable of detecting various biomolecules by utilizing different aptamers
on a single platform. The present work lays the ground for developing a wide range of
personalized point-of-care testing tools for therapeutic applications.
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CHAPTER 4: MULTIPLEX VIRAL DETECTION SYSTEM BASED ON
APTAMERS INTEGRATED MICROFLUIDIC CHANNEL
4.1

Introduction

Zika virus (ZIKV) is a mosquito-borne virus which is vectored by Aedes family (aegypti
and albopictus) and is known to pose a serious threat to the population worldwide. Nearly
440k-1300k cases associated with microcephaly and central nervous system
abnormalities were reported during Zika outbreak in Brazil in 2015[179, 180]. Besides
Brazil, cases associated with Zika infection have also been reported in 66 other countries
till date [181]. The world health organization declared a Public Health Emergency of
International Concern (PHEIC) in 2016 due to the increase in microcephaly cases and
neurological disorders that were generated by the Zika virus.[182] More than 5k cases
since 2016 have been confirmed in United States alone as confirmed by Pan American
Health Organization[179]. The transmission of Zika occurs through infected mosquito bite,
in utero mother to fetus and sexual contact. Zika infection is usually asymptomatic,
however sometimes non-specific symptoms such as rash, fever, headache, vomiting and
joint pains of varying degrees can be observed [183, 184]. These symptoms overlap
significantly with other flaviviruses infection such as Chikungunya (CHIKV). Due to a
shared vector as well as non-specific symptoms, adequate diagnosis of Zika at an early
stage poses a serious challenge specially in resource constrained communities where
both the viral infection are endemic.
The current diagnostic tools for the detection of Zika virus depend mostly on RTPCR (reverse transcription polymerase chain reaction)[183], RT-LAMP (reverse70

transcription loop-mediated isothermal amplification)[185-189] and RT-RPA (reverse
transcription recombinase polymerase amplification)[190] coupled with external power
source and a display unit such as smart phone for an easy readout signal.[191-197] These
techniques often require expensive instrumentation, skilled labor and sometimes faces
major disadvantage of false negative/positive results arising from new strains or
contamination.[198] Other methods for Zika diagnosis such as IgM-capture ELISA and
plaque reduction neutralization test (PRNT) face a major challenge of cross-reactivity with
other flaviviruses[198] leading to ambiguous results. Therefore, there is a dire need for
the development of novel, compact and passive point-of-care (POC) testing tools which
can provide multiplexed diagnosis in a rapid and cost-effective manner.
To this end, we have fabricated a flexible, portable, easy-to-use aptamer based
microfluidic sensor for the multiplex detection of recombinant Zika and CHIKV envelope
proteins. Aptamers are short single-stranded oligonucleotides that are designed using in
vitro SELEX (Systematic Evolution of Ligands by Exponential enrichment) process to bind
to a specific target with high specificity and affinity. Aptamers offers several advantages
over antibodies such as stability in harsh environment, ease of synthesis and
functionalization, high batch to batch consistency and wide variety of targets.[199-202]
The use of microfluidic platform allows for the manipulation of fluids at the micron-scale
and are used to implement operations that require large, expensive equipment onto a
micro-sized device.[203, 204] The compatibility of polydimethylsiloxane (PDMS) with
microfluidic fabrication offers flexibility and optical transparency which enhances the
colorimetric signal obtained in the presence of analytes produced during the test.
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Figure 28: Schematic representation of the current approach based on sandwich assay
for the detection of multiple viral proteins on a single platform. The surface is first
conjugated with a linker molecule, PMPI which attaches to thiolated end of the aptamers
(1). Control site is blocked with BSA molecule. The infected sample containing viral
protein is introduced in the channel where the specific aptamers bind to their specific
proteins (2). AuNPs conjugated with aptamers is then allowed to bind to a different
epitope on the protein forming a sandwich morphology (3). If no protein is present, all
the AuNPs will be washed off. In the end, silver reagents are introduced in the channel
which deposits over the surface of AuNPs giving a colorimetric signal to the presence of
viral protein (4).
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The current sensor depends on the engineered sandwich assay with Aptamer1-AntigenAptamer2 for the detection of ZIKA and CHIKV antigens (Figure 28). The Aptamer1 is
immobilized on the microfluidic channel which captures the incoming protein present in
the infected samples. The Aptamer2 conjugated with gold nanoparticles (AuNPs) is used
to report the presence of antigen by generating an output signal in the form of color
change. Development of silver around the AuNPs results in dark gray color depending on
the concentration of protein which amplifies the color change in the channel. The major
advantage of using antigen-capture sandwich assay is high sensitivity and colorimetric
detection capabilities with crude sample preparation.[205] The approach is similar to the
ELISA technique but avoids the use of expensive plates and plate readers, and is very
easy to handle. Also, the replacement of antibodies with the aptamers makes this
technique more robust while maintaining the accuracy and reliability of the approach.

4.2
4.2.1

Materials and Methods
Chemical reagents

Recombinant Zika envelope protein (ZKV-005) and Chikungunya type E1 (CHI-001) were
obtained from Prospecbio (Israel). The protein samples were provided to BasePair
Biotechnologies (Pearland, TX) for a custom-made set of aptamers. The aptamers
showing highest binding affinity were used for experimentation. Aptamer folding buffer,
reducing buffer and resuspension buffer were also provided by Basepair Biotechnologies
to prepare the aptamers for immobilization. Other chemicals such as Gold(III) chloride
trihydrate, trisodium citrate, phosphine buffered saline tablets, sodium hydroxide,
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hexamethyldisilazane (HMDS), acetonitrile and magnesium chloride (MgCl2) were
purchased from Sigma-Aldrich (St. Louis, MZ). PMPI (p-maleimidophenyl isocyanate)
used for the functionalization of PDMS was obtained from Thermofisher (Waltham, MA).
Dow Corning Sylgard 184 Silicone Encapsulant Clear Kit for the fabrication of microfluidic
channels was purchased from Ellsworth (Germantown, WI). SU8 and SU8 developer
used during photolithography was purchased from MicroChem (Westborough, MA). The
masks were printed by CAD/Art Servies (Bandon, OR). The silver enhancement kit was
purchased from Cytodiagnostics (Burlington, ON). Silicon wafers were obtained from
Waferworld Inc. (West Palm Beach, FL). The entire study was done using DNAse-RNAse
free water, vials and pipette tips obtained from Thermofisher.

4.2.2

Fabrication of microfluidic channel

Fabrication of Master mold: PDMS based microfluidic channels were fabricated using
a soft lithography technique. [206] The silicon wafers were cleaned thoroughly by rinsing
with acetone, isopropanol and water, followed by nitrogen blow. These were kept at 80 oC
for 15 min to evaporate any residual water. After cleaning, the wafers were pretreated
with HMDS overnight to improve the adhesion between the photoresist layer and wafer
surface. The HMDS treated wafers were deposited with SU8 photoresist for the
development of master mold. The wafer was centered on rotating stage of the spin coater
and a dollop of SU8-2050 was poured in the center. SU-8 was spincoated over the wafer
at 2500 rpm for 50 sec which gave an average thickness of 70 m of the layer. After
spinning, the wafer was soft baked at 65 oC for 3 min followed by 95oC for 8 min. The
wafer was allowed to cool at room temperature for atleast 5 min. The next step in the
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lithography is to transfer the pattern of the mask onto the SU8 deposited Si wafer. The
mask was placed over the Si wafer in the mask aligner and exposed to UV (275 nm) for
50 sec. After UV exposure, the silicon wafers were baked for 1 min at 65 oC followed by a
6 min bake at 95oC. Upon cooling, the wafers were developed in copious amount of SU8 developer for 5 min, followed by rinsing with Isopropanol. If white streaks were seen,
the wafers were again kept in fresh developer solution for few seconds and then rinsed
with IPA. The developed wafers were dried using nitrogen blow and baked at 95 oC for 3
min. The fabricated master molds were silanized using tricholorsilane for 2 hours under
vacuum to make the peeling step easier.

Development of Microfluidic channels: The PDMS mixture was formed by adding the
base and cross-linker (provided in the Dow Corning kit) in 10:1 weight ratio in a disposable
plastic weigh boat. The mixture was thoroughly mixed with a plastic-stir rod until it became
cloudy and suspended with air bubbles. The air bubbles were removed by placing the
boat under vacuum in a desiccator and venting it periodically. Once all the air bubbles
were removed, the PDMS mixture was poured slowly on to the master mold in a petri
dish. The petri dish was then placed in a pre-heated oven at 65oC for 1 hour to cure. After
curing, the PDMS hardened over the mold and took the features of the mold as shown in
Figure 29A. It was then peeled off carefully and individual channels were cut using a
sharp blade.

Surface treatment of Microfluidic channels: The microfluidic channels were treated
with 1 mM NaOH solution at room temperature for 16 hours under gentle shaking. The
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samples were then washed thoroughly with DNase-RNase free water, followed by drying
with nitrogen blow. After this, PMPI dissolved in acetonitrile (10 mg/ml) was applied onto
the testing regions and kept for 3 hours at room temperature. The surface treatment of
PDMS with PMPI offers a free maleimide group which shows high affinity towards thiol
bond present at the end of aptamers. The samples were washed with acetonitrile and
working buffer (1 mM MgCl2, 1X PBS, pH 7.5) thrice before conjugating with aptamers.

4.2.3 Preparation of aptamers and immobilization
The obtained thiolated aptamers (both CHIKV and Zika) were dissolved in resuspension
buffer to obtain a 100 M stock concentration. The aptamers were diluted to 50 M using
folding buffer and heated at 95oC for 5 min. Then, these were cooled to room temperature
for 15 min. This allows the aptamers to fold properly and attain their native conformation
required for binding to the target molecule. After 15 min, the aptamer solution was mixed
with the reducing buffer (TCEP) in 1:1 ratio (v/v) to obtain a final concentration of 25 M
and kept at room temperature for another 20 min. The TCEP is used to cleave the
disulphide bonds (-S-S-) which allows for free –SH group. The -SH group plays a major
role in binding of the aptamers to the Gold Nanoparticles as well as PDMS surface.

Immobilization on AuNPs: 13 nm citrate capped AuNPs prepared using standard
Turkevich method were used in the present study. The aptamers were immobilized on
AuNPs surface by incubating 1 ml of AuNPs (0.2 mg/ml) with 20 M (10 l) of reduced
aptamers at room temperature with gentle stirring overnight. The AuNPs solution was
then centrifuged down (11000 rcf, 11 min) to remove unbound aptamers and
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resuspended in working buffer. The conjugation of aptamers was confirmed by performing
gel electrophoresis on the bare as well as aptamer conjugated AuNPs.

Immobilization on PDMS: The prepared aptamers were added directly to the
functionalized testing zone on the microfluidic channel and allowed to sit for 3 hours with
gentle stirring. The final concentration of the aptamers used for each testing zone was 25
M, 20 l. After 3 hours of incubation, the channels were washed gently with working
buffer to remove unbound aptamers. To avoid non-specific binding of the protein, the
channels were then passivated using 1% BSA for 1 hour.

4.3

Results and Discussion

4.3.1 Development of microfluidic channel
The fabricated microfluidic channels were integrated with micro-sized pillars to increase
the surface area in the testing region. The enhanced surface area ensured more number
of aptamers in the testing zone which increased the binding sites for the protein
molecules, thus enhancing the sensitivity of the approach. The SEM analysis shown in
Figure 29B confirms the presence of pillars in the magnified view of the testing zone. The
analysis of the vertical and lateral view (inset) indicates that the pillars have an average
diameter and height of 50 m and 45 m respectively.
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Figure 29: (A) Fabrication process of microfluidic channels using a Si master mould.
PDMS is poured carefully and cured at 65oC for 1 hour. Next step shows peeling off the
layer from the mould and channels being formed in the PDMS layer. (B) Image of a
single microfluidic channel. SEM image representing magnified view of the testing zone
showing the presence of pillars with an average diameter of 50 µm. (C) FTIR
spectroscopy of the microfluidic channel at different steps of functionalization: NaOH,
PMPI and aptamers treatment. Peaks at 1698 cm-1 and 1531 cm-1 represents amide I
and amide II bands in PMPI which shows the presence of urethane linkage. (D)
Schematic representation of the functionalization of the channel using PMPI as the
linker molecule to immobilize aptamers. (E, F) UV-visible spectroscopy and TEM
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analysis of the Turkevich method based Gold nanoparticles. Inset shows narrow size
distribution of the particles in the range of 15-20 nm as measured by DLS. (G) Gel
Electrophoresis of the bare and aptamer conjugated AuNPs. Migration is observed in
the aptamer conjugated samples due to the negative charge on the particle surface.

4.3.2 Functionalization of Microfluidic channel
The microfluidic channels were first treated with aqueous solution of NaOH to make the
surface hydrophilic in nature. The treatment with NaOH introduces hydroxyl group (-OH)
at the surface which not only improves the flow but also facilitates functionalization of the
surface with other chemicals.[207-209] The major advantage of using NaOH over
traditional ozone treatment is the enhanced stability of the samples irrespective of the
storage condition. In the second step, the -OH groups were allowed to react with PMPI
which is used as a linker molecule between aptamers and PDMS surface. The isocyanate
end (-N=C=O) of PMPI interacts with -OH and forms urethane linkage. This renders the
maleimide end available for coupling with the thiol group present at the end of
aptamers.[210-212] The schematic of the reaction is shown in Figure 29D. The FTIR
spectra (Figure 29C) exhibit different characteristic peaks obtained during the surface
treatment of PDMS with NaOH, PMPI and aptamers. The FTIR spectrum of PDMSNaOH-PMPI showed peaks at 1698 cm-1 and 1531cm-1 which corresponds to Amide I and
Amide II bands (C=O stretching and –N-H bending) respectively.[211, 213, 214] A distinct
peak at 1585 cm-1 is also observed which points to the presence of C=C in the maleimide
group. After the immobilization of the aptamers, a significant peak at ~3410 cm-1 is
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observed which is due to large number of hydroxyl groups present at the end of aptamers.
A peak at 1648 cm-1 is also seen which indicates the presence of the purine and pyrimidine
rings in the aptamers.[215] The FTIR data confirmed the immobilization of the aptamers
over PDMS using PMPI as the linker molecule.

4.3.3 Gold nanoparticles synthesis and functionalization
The Gold nanoparticles were synthesized using a standard Turkevich method in which
gold chloride precursor salt is reduced using trisodium citrate at high temperature. The
characterization of the synthesized AuNPs is shown in Figure 29E and 29F. The TEM
results indicate that the particles are uniformly distributed and spherical in nature with an
average diameter of 13 nm. The UV visible spectrum (Figure 29E) shows a distinctive
absorbance peak at 520 nm which represents the surface plasmon band of AuNPs. The
particles were conjugated with Zika and CHIKV aptamers using a standard protocol at a
concentration of 200 nM. The successful conjugation of the aptamers over the AuNPs
was confirmed by running the particles through 0.5% agarose gel under the influence of
voltage (Figure 29G). It was observed that the aptamer conjugated AuNPs migrated
through the gel (red arrow) whereas the bare AuNPs remained in the well (black arrow).
The migration of conjugated particles is due to the overall negative particle charge
imparted by the conjugated aptamers, which enables these Apt-AuNPs to be driven
through the gel in response to the applied voltage.
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4.3.4 Testing of Microfluidic channel
The present approach was first tested on a PDMS substrate to examine the sensitivity
and selectivity of aptamers for the target arboviral envelope proteins. A distinct color
development was observed from 500 pM of CHIKV envelope protein, which intensified
with increasing protein concentrations (Figure 30). The approach was then extended to
the microfluidic channels with a controlled flow rate (80µL/min). The aptamer-conjugated
microfluidic channels were tested against different concentration (10 fM-1 nM) of both
CHIKV and ZIKV envelope proteins. Figure 31A shows distinct development of silver in
the testing zones represented by circles. The ‘+’ and ‘-’ sign indicates the presence or
absence of the specific arboviral envelope protein in the testing solution. For 0 nM, the
PBS was spiked with BSA which was used as the negative control to test non-specific
interactions of AuNPs in the channel. No color development was observed in the negative
control regions in any of the channels, which indicates high specificity of the Apt-AuNPs.
Also, for the last two channels, only one viral envelope protein (either ZIKV or CHIKV)
was injected as per (+) or (-) symbol. It can be seen that ZIKV envelope protein at a very
high concentration of 10 nM did not interfere with the CHIKV aptamers and vice versa.
This clearly suggests that the current approach is not only highly sensitive with a detection
limit of 1 pM but also exhibits high level of selectivity among different arboviruses such as
ZIKV and CHIKV.
The color change in the channels was also measured using an image processing
software to calculate the CMYK (cyan, magenta, yellow and key) values. The key value
represents the black color that was used as the measure of silver development in the
microfluidic channels. The more numbers of AuNPs results in increased silver deposition
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in the testing zone, leading to an intense color change. Figure 31B shows the key value
with respect to concentration of protein. It can be seen that with increasing protein
concentration, K value increases. The measure of K value can be used for a quantitative
estimation of the arboviral envelope protein concentration present in the sample.
The microfluidic device was also tested against sterile, mechanically-defibrinated
calf blood and complete sheep se-rum spiked with the given ZIKV and CHIKV
recombinant envelope proteins as surrogates for infected human blood/blood products.
The results are represented as black key color (K) as a function of protein concentration
(Figure 32). The testing showed a response to as low as 1 pM of the recombinant protein
in PBS and 10 pM when tested against spiked 10% calf blood (diluted with working buffer)
or sheep serum. In the case of undiluted (i.e., 100%) calf blood, a slight increase in K
value was observed in the presence of 100 pM (~5 ng/ml) of the protein. Diluting the blood
with the binding buffer therefore increased the sensitivity of the system by ~10 fold. A
comparative analysis of different detection techniques is shown in Table S1. The present
sensor gives a minimum detection limit of 1 pM (50 pg/ml) for the ZIKV envelope protein
and the CHIKV envelope protein E1 in PBS which is the lowest obtained so far. The
similar detection limit (in buffer) was also obtained by Zeng et. al. using an antibodyaptamer mediated sandwich assay on a 96-well ELISA plate[216]. The current approach
abrogates the use of expensive plates or sophisticated plate reader making the device
more adoptable in re-source constrained areas.
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Figure 30: PDMS substrate for the detection of CHIKV protein

Figure 31: (A) Digital image of the microfluidic channels representing color change in
the testing zones in presence of different concentration of protein (1 pM, 10 pM, 100
pM, 1 nM). The last two channels represent the specificity of the current sensor. The
sample containing only ZIKV protein (10 nM) was introduced in the channel and no
color change in the CHIKV region was observed and vice versa. This shows that the
aptamers are highly specific in nature. (B) Graph represents the change in Key value
(CMYK color model) calculated using ImageJ as a function of concentration of protein.
Black and white are represented 100 and 0 respectively. It can be seen that the Key
value moves towards black attributing to the increased deposition of Silver in the testing
zone.
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Table 3: Comparative analysis of different techniques used to detect the presence of
Zika infection.

Limit of

Analyte

Method

Zika RNA

RT-RPA

5 PFU/mL

Zika RNA

RT-LAMP

50 PFU/ml

Zika NS1

ELISA

Detection

0.1 ng/ml (2

NS1
(flaviviruses)
NS1
(flaviviruses)
E protein
(ZIKV)

Impedimetric

Capacitance

pM)

3 ng/mL, 30
ng/mL
0.2 ng/mL,
0.5 ng/mL

Detection Mode

Reference

Mobile phone

[190]

Naked eyeColorimetric
UV absorbanceColorimetric

[186]

[216]

Potentiostat

[217]

Potentiostat

[217]

Electro-generated
Chemiluminescence

10 PFU/mL

chemiluminescence

[218]

instrument

Zika NS1

Commercially

protein-

available ELISA kits

Zika,

Nanoparticle

50 pg/ml (1

Naked eye-

Current

Chikungunya

immunoassay

pM)

Colorimetric

work

0.1 ng/ml
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UV absorbanceColorimetric

[219] [220]

Figure 32: Development of silver in the microfluidic channels as a function of different
concentration of ZIKV and CHIKV envelop proteins (1 pM, 10 pM and 100 pM) has been
represented in terms of Key value (CMYK color code). No change in K values for calf
blood and sheep serum was observed in the presence of 1 pM of the protein. Serum
and 10% calf blood exhibited a slight color development at 10 pM of the recombinant
protein. In case of 100 pM, distinct color development was observed in all the three
cases.
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4.4

Summary

In summary, a multiplex detection system for ZIKV and CHIKV arboviral envelope
proteins has been developed using an aptamer-conjugated microfluidic channel
approach. This novel method implements the immobilizing aptamers to the PDMS
substrate using PMPI as the linker molecule. The channels are patterned with microsized
pillars that facilitate an enhanced sensitivity of the approach down to detections of 1 pM
(50 pg/ml) of viral envelope protein targets in PBS and 10 pM in dilute (10%)
mechanically-defibrinated calf blood. The detection is based on a silver-enhancement
technique that deposits a thick silver shell over the surface of target-bound Apt-AuNPs.
This enhancement enables significant color changes on the PDMS substrate indicating
the presence of target protein. The device also exhibited high specificity towards target
protein with no interference from other, off-target arboviral proteins. The use of aptamers
as the biorecognition molecule provides flexibility to incorporate additional or alternative
targets by designing the specific aptamers and immobilizing them in the microfluidic
channel. The present approach can be extended to detect other clinically important
biomarkers for which there are few POC options available.
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CHAPTER 5: CONCLUSIONS
The present work successfully exhibited the development of unique biosensors detecting
small biomolecules as well as viral protein such as Zika. These approaches provide a
real-time detection of a large range of biomolecules and viral proteins in a time and costeffective manner and has applications in point-of-care testing tool for several diagnostics.
In the first chapter, colorimetric detection of epinephrine molecules has been
demonstrated using a simple paper based substrate. Epinephrine is an excitatory
neurotransmitter which plays an important role in the functioning of different biological
reactions. The present sensor utilized aptamers functionalized gold nanoparticles as the
colorimetric probes to induce a color change (red to blue) in the solution in the presence
of epinephrine molecule. The study also investigated role of different parameters such as
morphology of AuNPs (size and shape), aptamer concentration and salt destabilization
to achieve a highly sensitive and selective biosensor. It was observed that the size and
shape of the gold nanoparticles played most important role in controlling the detection
limit of the sensor. The sensor exhibited a detection limit of 900 pM for epinephrine giving
colorimetric signal which has not been achieved in any other study till date.
The second chapter emphasizes on the detection of epinephrine using a
PEDOT:PSS based organic electrochemical transistor platform. The Au gate electrode
was functionalized using epinephrine binding aptamers which acts as transducer. In the
presence of epinephrine molecule, a significant decrease in the channel current was
observed in the transfer characteristics as well as chronoamperometric measurements.
This effect is attributed to the screening of the negative charge of aptamers and oxidation
of epinephrine which increases the effective gate voltage resulting in a decrease in
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current. The device was found to be highly sensitive towards epinephrine with a limit of
detection of 90 pM which is less than the normal physiological range in humans (120 pM).
Also, the device did not show any response towards common interfering agents such as
dopamine, ascorbic acid, DOPAC etc. The approach provides a platform for the real-time
detection of large range of biomolecules and viral proteins in a timely and efficient
manner.
In the third chapter, the development of an aptamer based microfluidic sensor to
detect multiple viral proteins has been shown. The working principle of the sensor is
based on the formation of sandwich type morphology among aptamer-analyte-aptamergold which induces color change visible to naked eye. Silver reagent has been used to
enhance the color change. The sensor showed high affinity towards zika and CHIKV
protein and no interference was observed by control sample. The colorimetric detection
limit of the sensor has been found to be 1 pM (50 pg/ml) of viral envelope protein targets
in PBS and 10 pM in dilute (10%) mechanically-defibrinated calf blood which is relevant
to the practical applications. The use of microfluidic channel enables multiplex detection,
integrates the whole system and reduces the complexity of the assay. The current sensor
provides rapid, easy and cheap sensing technique with high sensitivity and selectivity,
leading to a more consumer driven health care.
The major advantage of employing aptasensors is that it can be designed for a
large number of analyte molecules which offers a great potential to be applied in the fields
of bioassay, biomedical diagnostic or environmental monitoring. The current work
presents a set of tool box which provides a multiplex detection system for different viral
proteins and show huge potential to be used in real world applications. Successful
88

implementation of these current sensors provides a means to a highly efficient, low cost,
rapid and easy-to-use point of care diagnostic tools.

89

APPENDIX A: COPYRIGHT PERMISSION LETTER FOR FIGURE 1

90

8/22/2018

Rightslink® by Copyright Clearance Center

Title:

Multiplexed PointofCare
Testing – xPOCT

Logged in as:

Author:

Can Dincer,Richard Bruch,André
Kling,Petra S. Dittrich,Gerald A.
Urban

Account #:
3001306138

Nileshi Saraf

Publication: Trends in Biotechnology
Publisher:

Elsevier

Date:

August 2017

© 2017 The Authors. Published by Elsevier Ltd.

Creative Commons AttributionNonCommercialNo Derivatives License (CC BY NC ND)
This article is published under the terms of the Creative Commons AttributionNonCommercialNo
Derivatives License (CC BY NC ND).
For noncommercial purposes you may copy and distribute the article, use portions or extracts from
the article in other works, and text or data mine the article, provided you do not alter or modify the
article without permission from Elsevier. You may also create adaptations of the article for your own
personal use only, but not distribute these to others. You must give appropriate credit to the original
work, together with a link to the formal publication through the relevant DOI, and a link to the
Creative Commons user license above. If changes are permitted, you must indicate if any changes
are made but not in any way that suggests the licensor endorses you or your use of the work.
Permission is not required for this noncommercial use. For commercial use please continue to
request permission via Rightslink.

Copyright © 2018 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement. Terms and Conditions.
Comments? We would like to hear from you. Email us at customercare@copyright.com

https://s100.copyright.com/AppDispatchServlet

1/1

91

APPENDIX B: COPYRIGHT PERMISSION LETTER FOR FIGURE 2

92

93

APPENDIX C: COPYRIGHT PERMISSION LETTER FOR FIGURE 3

94

8/20/2018

Rightslink® by Copyright Clearance Center

Title:

Author:

Gold nanoparticles as efficient
sensors in colorimetric detection
of toxic metal ions: A review
E. Priyadarshini,N. Pradhan

Logged in as:
Nileshi Saraf
Account #:
3001306138

Publication: Sensors and Actuators B:
Chemical
Publisher:

Elsevier

Date:

January 2017

© 2016 Published by Elsevier B.V.

Review Order
Please review the order details and the associated terms and conditions.
No royalties will be charged for this reuse request although you are required to obtain a license and
comply with the license terms and conditions. To obtain the license, click the Accept button below.
Licensed Content
Publisher

Elsevier

Licensed Content
Publication

Sensors and Actuators B: Chemical

Licensed Content Title

Gold nanoparticles as efficient sensors in colorimetric detection of toxic metal ions: A review

Licensed Content Author

E. Priyadarshini,N. Pradhan

Licensed Content Date

January 2017

Licensed Content Volume 238
Licensed Content Issue

n/a

Licensed Content Pages

15

Type of Use

reuse in a thesis/dissertation

Portion

figures/tables/illustrations

Number of
1
figures/tables/illustrations
Format

both print and electronic

Are you the author of this No
Elsevier article?
Will you be translating?

No

Original figure numbers

Figure 2

Title of your
thesis/dissertation

Development of in vitro point of care diagnostics (IVPCD) based on Aptamers integrated
Biosensors.

Expected completion date Dec 2018
Estimated size (number
of pages)

140

Requestor Location

Ms. Nileshi Saraf
3060, White Ash Trail
Knights Landing
ORLANDO, FL 32826
United States
Attn: Ms. Nileshi Saraf

Publisher Tax ID

980397604

Total

0.00 USD

Edit Order Details
Edit Requestor Location

This location may be used to determine your tax liability.

I agree to these terms and conditions.
https://s100.copyright.com/AppDispatchServlet

1/2

95

APPENDIX D: COPYRIGHT PERMISSION LETTER FOR FIGURE 4

96

8/20/2018

Rightslink® by Copyright Clearance Center

Title:

Author:

A short history, principles, and
types of ELISA, and our
laboratory experience with
peptide/protein analyses using
ELISA

Logged in as:
Nileshi Saraf
Account #:
3001306138

Suleyman Aydin

Publication: Peptides
Publisher:

Elsevier

Date:

October 2015

Copyright © 2015 Elsevier Inc. All rights reserved.

Review Order
Please review the order details and the associated terms and conditions.
No royalties will be charged for this reuse request although you are required to obtain a license and
comply with the license terms and conditions. To obtain the license, click the Accept button below.
Licensed Content
Publisher

Elsevier

Licensed Content
Publication

Peptides

Licensed Content Title

A short history, principles, and types of ELISA, and our laboratory experience with
peptide/protein analyses using ELISA

Licensed Content Author

Suleyman Aydin

Licensed Content Date

October 2015

Licensed Content Volume 72
Licensed Content Issue

n/a

Licensed Content Pages

12

Type of Use

reuse in a thesis/dissertation

Portion

figures/tables/illustrations

Number of
1
figures/tables/illustrations
Format

both print and electronic

Are you the author of this No
Elsevier article?
Will you be translating?

No

Original figure numbers

figure 1

Title of your
thesis/dissertation

Development of in vitro point of care diagnostics (IVPCD) based on Aptamers integrated
Biosensors.

Expected completion date Dec 2018
Estimated size (number
of pages)

140

Requestor Location

Ms. Nileshi Saraf
3060, White Ash Trail
Knights Landing
ORLANDO, FL 32826
United States
Attn: Ms. Nileshi Saraf

Publisher Tax ID

980397604

Total

0.00 USD

Edit Order Details
Edit Requestor Location

This location may be used to determine your tax liability.

https://s100.copyright.com/AppDispatchServlet

1/2

97

APPENDIX E: COPYRIGHT PERMISSION LETTER FOR FIGURE 5

98

7
/
29
/
20
1
8

P
ubMe
dCe
ntr
a
l,
Fig
ur
e1
.
:Se
nsor
s(
Ba
se
l)
.
20
0
8Ma
r
;8(
3)
:1
40
0
–
1
458.
P
ublish
e
donline20
0
8Ma
r7
.
doi:1
0
.
339
0
/
s80
31
40
0
0

PMC full text: Sensors (Basel). 2008 Mar; 8(3): 1400–1458.
Published online 2008 Mar 7. doi: 10.3390/s80314000
Copyright/License ▼
Request permission to reuse

<< Prev

Figure 1.

Next >>

Copyright © 2008 by MDPI
Reproduction is permitted for noncommercial purposes.

Figure 1.

Elements and selected components of a typical biosensor [1, 2, 3].
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